| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.74 | 0.002 | 0.804 | Peroxidase inhibitor | 0.426 0.017 CID_321710 0.68 0.003 CID_50591 0.804 0.002 CID_524508 | CID_524508 | |
| 0.73 | 0.005 | 0.73 | 5 Hydroxytryptamine release stimulant | 0.618 0.013 CID_321710 0.729 0.005 CID_50591 0.681 0.008 CID_524508 | ||
| 0.723 | 0.003 | 0.743 | GABA C receptor rho-3 antagonist | 0.617 0.006 CID_321710 0.695 0.003 CID_50591 0.743 0.002 CID_524508 | CID_524508 | |
| 0.664 | 0.004 | 0.664 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.587 0.009 CID_321710 0.539 0.019 CID_50591 0.558 0.014 CID_524508 | ||
| 0.564 | 0.009 | 0.564 | MAP kinase kinase 6 inhibitor | 0.283 0.153 CID_321710 0.274 0.162 CID_50591 0.468 0.027 CID_524508 | ||
| 0.547 | 0.014 | 0.584 | Calcium channel L-type activator | 0.554 0.012 CID_321710 0.578 0.008 CID_50591 0.584 0.007 CID_524508 | CID_524508 | |
| 0.531 | 0.005 | 0.531 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.36 0.032 CID_321710 0.328 0.047 CID_50591 0.487 0.009 CID_524508 | ||
| 0.49 | 0.003 | 0.49 | GABA C receptor rho-2 antagonist | 0.316 0.005 CID_321710 0.406 0.003 CID_50591 0.474 0.003 CID_524508 | ||
| 0.501 | 0.014 | 0.52 | Dyrk kinase inhibitor | 0.153 0.133 CID_321710 0.209 0.094 CID_50591 0.52 0.012 CID_524508 | CID_524508 | |
| 0.491 | 0.009 | 0.491 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.283 0.048 CID_321710 0.155 0.107 CID_50591 0.346 0.029 CID_524508 | ||
| 0.511 | 0.029 | 0.519 | 5 Hydroxytryptamine release inhibitor | 0.513 0.028 CID_321710 0.519 0.027 CID_50591 0.507 0.03 CID_524508 | CID_50591 | |
| 0.485 | 0.014 | 0.518 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.158 0.124 CID_321710 0.213 0.085 CID_50591 0.518 0.011 CID_524508 | CID_524508 | |
| 0.485 | 0.035 | 0.615 | Aldehyde oxidase inhibitor | 0.392 0.048 CID_321710 0.593 0.02 CID_50591 0.615 0.017 CID_524508 | CID_524508 | |
| 0.476 | 0.026 | 0.476 | Aryl hydrocarbon receptor agonist | 0.251 0.078 CID_321710 0.444 0.03 CID_50591 0.437 0.031 CID_524508 | ||
| 0.456 | 0.01 | 0.456 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.325 0.029 CID_321710 0.191 0.084 CID_50591 0.35 0.023 CID_524508 | ||
| 0.432 | 0.015 | 0.432 | Calcium channel activator | 0.408 0.022 CID_321710 0.403 0.024 CID_50591 0.43 0.015 CID_524508 | ||
| 0.429 | 0.013 | 0.429 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.38 0.021 CID_321710 0.145 0.092 CID_50591 0.332 0.029 CID_524508 | ||
| 0.429 | 0.013 | 0.429 | Death-associated protein kinase 3 inhibitor | 0.238 0.057 CID_321710 0.16 0.108 CID_50591 0.316 0.034 CID_524508 | ||
| 0.425 | 0.027 | 0.46 | Interleukin antagonist | 0.232 0.068 CID_50591 0.46 0.023 CID_524508 | CID_524508 | |
| 0.412 | 0.015 | 0.412 | EphB2 antagonist | 0.337 0.026 CID_524508 | ||
| 0.468 | 0.074 | 0.583 | Caspase 9 stimulant | 0.43 0.094 CID_321710 0.52 0.052 CID_50591 0.583 0.039 CID_524508 | CID_524508 | |
| 0.403 | 0.014 | 0.403 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.176 0.112 CID_321710 0.188 0.1 CID_50591 0.294 0.041 CID_524508 | ||
| 0.406 | 0.018 | 0.406 | Clk dual-specificity kinase inhibitor | 0.265 0.049 CID_524508 | ||
| 0.442 | 0.054 | 0.496 | Histamine release inhibitor | 0.459 0.046 CID_321710 0.496 0.03 CID_50591 0.475 0.038 CID_524508 | CID_50591 | |
| 0.37 | 0.003 | 0.37 | 5 Hydroxytryptamine 3E antagonist | 0.268 0.01 CID_321710 0.312 0.004 CID_50591 0.278 0.008 CID_524508 | ||
| 0.373 | 0.008 | 0.373 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.273 0.025 CID_321710 0.112 0.091 CID_50591 0.247 0.032 CID_524508 | ||
| 0.415 | 0.051 | 0.521 | Vasodilator, peripheral | 0.521 0.024 CID_321710 0.359 0.07 CID_50591 0.401 0.055 CID_524508 | CID_321710 | |
| 0.372 | 0.009 | 0.372 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.254 0.061 CID_321710 0.214 0.13 CID_50591 0.261 0.053 CID_524508 | ||
| 0.379 | 0.016 | 0.379 | CDC-like kinase 2 inhibitor | 0.246 0.047 CID_524508 | ||
| 0.372 | 0.013 | 0.372 | Protein kinase C nu inhibitor | 0.198 0.048 CID_321710 0.247 0.035 CID_524508 | ||
| 0.372 | 0.014 | 0.372 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.183 0.09 CID_321710 0.165 0.106 CID_50591 0.287 0.031 CID_524508 | ||
| 0.363 | 0.008 | 0.363 | 5 Hydroxytryptamine 1E antagonist | 0.293 0.034 CID_321710 0.318 0.02 CID_50591 0.331 0.015 CID_524508 | ||
| 0.367 | 0.013 | 0.424 | Tyrosine 3 hydroxylase inhibitor | 0.393 0.009 CID_321710 0.424 0.006 CID_50591 0.421 0.006 CID_524508 | CID_50591 | |
| 0.346 | 0.004 | 0.346 | MAP kinase kinase 3 inhibitor | 0.207 0.103 CID_321710 0.196 0.135 CID_50591 0.262 0.022 CID_524508 | ||
| 0.344 | 0.003 | 0.344 | Protein kinase C theta inhibitor | 0.06 0.036 CID_50591 0.165 0.004 CID_524508 | ||
| 0.347 | 0.008 | 0.347 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.126 0.1 CID_50591 0.33 0.01 CID_524508 | ||
| 0.347 | 0.011 | 0.347 | MAP-kinase-activated kinase 5 inhibitor | 0.211 0.091 CID_321710 0.207 0.095 CID_50591 0.323 0.019 CID_524508 | ||
| 0.347 | 0.021 | 0.347 | CDC-like kinase 4 inhibitor | 0.191 0.072 CID_524508 | ||
| 0.329 | 0.004 | 0.33 | GABA C receptor antagonist | 0.266 0.005 CID_321710 0.303 0.004 CID_50591 0.33 0.004 CID_524508 | CID_524508 | |
| 0.358 | 0.035 | 0.384 | Superoxide dismutase inhibitor | 0.271 0.063 CID_321710 0.368 0.033 CID_50591 0.384 0.03 CID_524508 | CID_524508 | |
| 0.344 | 0.022 | 0.344 | MAP kinase kinase 2 inhibitor | 0.327 0.027 CID_321710 0.21 0.076 CID_50591 0.339 0.023 CID_524508 | ||
| 0.32 | 0.003 | 0.32 | GABA C receptor rho-1 antagonist | 0.234 0.005 CID_321710 0.273 0.004 CID_50591 0.301 0.003 CID_524508 | ||
| 0.318 | 0.006 | 0.318 | 5 Hydroxytryptamine 1 agonist | 0.056 0.034 CID_321710 0.261 0.008 CID_50591 0.054 0.035 CID_524508 | ||
| 0.344 | 0.036 | 0.345 | Insulysin inhibitor | 0.338 0.039 CID_321710 0.345 0.036 CID_50591 0.339 0.038 CID_524508 | CID_50591 | |
| 0.309 | 0.006 | 0.309 | Death-associated protein kinase 2 inhibitor | 0.285 0.008 CID_321710 0.211 0.027 CID_50591 0.262 0.011 CID_524508 | ||
| 0.331 | 0.031 | 0.526 | Cyclic AMP phosphodiesterase inhibitor | 0.526 0.005 CID_321710 0.211 0.086 CID_50591 0.326 0.033 CID_524508 | CID_321710 | |
| 0.33 | 0.032 | 0.347 | 5 Hydroxytryptamine uptake stimulant | 0.339 0.029 CID_321710 0.347 0.026 CID_50591 0.303 0.043 CID_524508 | CID_50591 | |
| 0.319 | 0.022 | 0.319 | Gastrin inhibitor | 0.307 0.029 CID_321710 0.299 0.034 CID_50591 0.271 0.056 CID_524508 | ||
| 0.302 | 0.009 | 0.33 | GABA C receptor agonist | 0.298 0.009 CID_321710 0.33 0.008 CID_50591 0.29 0.01 CID_524508 | CID_50591 | |
| 0.332 | 0.039 | 0.393 | Pyruvate kinase inhibitor | 0.265 0.057 CID_321710 0.352 0.033 CID_50591 0.393 0.022 CID_524508 | CID_524508 | |
| 0.296 | 0.004 | 0.296 | CYP2A6 inhibitor | 0.068 0.062 CID_321710 0.126 0.024 CID_50591 0.189 0.009 CID_524508 | ||
| 0.301 | 0.011 | 0.301 | 3C-like protease (Human coronavirus) inhibitor | 0.202 0.05 CID_321710 0.253 0.026 CID_50591 0.227 0.038 CID_524508 | ||
| 0.312 | 0.023 | 0.312 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.138 0.086 CID_321710 0.129 0.093 CID_50591 0.22 0.044 CID_524508 | ||
| 0.292 | 0.004 | 0.292 | Protein kinase C delta inhibitor | 0.106 0.048 CID_321710 0.124 0.034 CID_50591 0.234 0.005 CID_524508 | ||
| 0.281 | 0.004 | 0.281 | 5 Hydroxytryptamine 3A agonist | 0.23 0.008 CID_321710 0.228 0.008 CID_50591 0.242 0.006 CID_524508 | ||
| 0.296 | 0.018 | 0.321 | NOS3 expression enhancer | 0.133 0.094 CID_321710 0.154 0.068 CID_50591 0.321 0.015 CID_524508 | CID_524508 | |
| 0.295 | 0.019 | 0.295 | Protein kinase (CK1) gamma inhibitor | 0.158 0.063 CID_321710 0.154 0.065 CID_524508 | ||
| 0.281 | 0.005 | 0.281 | Protein kinase C mu inhibitor | 0.199 0.012 CID_524508 | ||
| 0.305 | 0.03 | 0.361 | RNA-directed DNA polymerase inhibitor | 0.293 0.033 CID_321710 0.288 0.034 CID_50591 0.361 0.023 CID_524508 | CID_524508 | |
| 0.29 | 0.021 | 0.29 | Protein kinase (CK1) gamma 1 inhibitor | 0.2 0.042 CID_321710 0.157 0.064 CID_524508 | ||
| 0.291 | 0.023 | 0.291 | LIM domain kinase 1 inhibitor | 0.194 0.066 CID_321710 0.162 0.086 CID_50591 0.253 0.037 CID_524508 | ||
| 0.28 | 0.012 | 0.28 | CDC-like kinase 1 inhibitor | 0.127 0.088 CID_50591 0.254 0.017 CID_524508 | ||
| 0.285 | 0.02 | 0.285 | Protein kinase (CK1) inhibitor | 0.122 0.09 CID_524508 | ||
| 0.269 | 0.005 | 0.269 | Protein kinase C gamma inhibitor | 0.258 0.006 CID_321710 0.2 0.014 CID_50591 0.262 0.005 CID_524508 | ||
| 0.276 | 0.014 | 0.276 | Interleukin 1 antagonist | 0.239 0.021 CID_524508 | ||
| 0.27 | 0.011 | 0.307 | Ferrochelatase inhibitor | 0.307 0.007 CID_321710 0.174 0.029 CID_50591 0.151 0.037 CID_524508 | CID_321710 | |
| 0.277 | 0.018 | 0.292 | Nitric-oxide synthase stimulant | 0.292 0.013 CID_321710 0.291 0.014 CID_50591 0.289 0.014 CID_524508 | CID_321710 | |
| 0.279 | 0.021 | 0.279 | Protein kinase (CK1) gamma 3 inhibitor | 0.187 0.055 CID_524508 | ||
| 0.263 | 0.005 | 0.263 | MAP kinase 11 inhibitor | 0.121 0.025 CID_524508 | ||
| 0.267 | 0.01 | 0.267 | MAP kinase 12 inhibitor | 0.167 0.033 CID_524508 | ||
| 0.265 | 0.009 | 0.265 | MAP kinase 13 inhibitor | 0.16 0.031 CID_524508 | ||
| 0.261 | 0.005 | 0.284 | CF transmembrane conductance regulator agonist | 0.176 0.04 CID_321710 0.278 0.004 CID_50591 0.284 0.004 CID_524508 | CID_524508 | |
| 0.288 | 0.035 | 0.288 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.235 0.053 CID_321710 0.178 0.076 CID_524508 | ||
| 0.259 | 0.007 | 0.308 | Protein kinase C zeta inhibitor | 0.111 0.039 CID_321710 0.189 0.013 CID_50591 0.308 0.005 CID_524508 | CID_524508 | |
| 0.275 | 0.025 | 0.277 | I kappa B kinase epsilon inhibitor | 0.213 0.06 CID_321710 0.166 0.103 CID_50591 0.277 0.024 CID_524508 | CID_524508 | |
| 0.254 | 0.004 | 0.254 | I kappa B kinase 1 inhibitor | 0.139 0.011 CID_524508 | ||
| 0.252 | 0.005 | 0.35 | Phenylalanine 4-hydroxylase inhibitor | 0.109 0.022 CID_321710 0.26 0.005 CID_50591 0.35 0.003 CID_524508 | CID_524508 | |
| 0.261 | 0.014 | 0.261 | Cyclin-dependent kinase 3 inhibitor | 0.235 0.02 CID_321710 0.175 0.054 CID_50591 0.221 0.024 CID_524508 | ||
| 0.254 | 0.008 | 0.254 | Rho-associated kinase inhibitor | 0.086 0.042 CID_524508 | ||
| 0.269 | 0.024 | 0.269 | Vascular endothelial growth factor 3 antagonist | 0.171 0.054 CID_321710 0.232 0.031 CID_524508 | ||
| 0.261 | 0.018 | 0.261 | Cyclin-dependent kinase 7 inhibitor | 0.13 0.076 CID_524508 | ||
| 0.261 | 0.018 | 0.261 | Protein kinase (CK1) gamma 2 inhibitor | 0.138 0.054 CID_321710 0.125 0.062 CID_524508 | ||
| 0.288 | 0.045 | 0.288 | Tyrosine kinase inhibitor | 0.175 0.078 CID_524508 | ||
| 0.275 | 0.038 | 0.275 | TRKC antagonist | 0.135 0.115 CID_321710 0.19 0.073 CID_524508 | ||
| 0.244 | 0.008 | 0.286 | Porphobilinogen synthase inhibitor | 0.158 0.019 CID_321710 0.278 0.006 CID_50591 0.286 0.005 CID_524508 | CID_524508 | |
| 0.265 | 0.03 | 0.323 | Focal adhesion kinase 2 inhibitor | 0.323 0.01 CID_321710 0.165 0.107 CID_50591 0.208 0.064 CID_524508 | CID_321710 | |
| 0.238 | 0.004 | 0.258 | Myeloperoxidase inhibitor | 0.098 0.037 CID_321710 0.193 0.005 CID_50591 0.258 0.004 CID_524508 | CID_524508 | |
| 0.293 | 0.06 | 0.338 | DNA damaging | 0.189 0.125 CID_321710 0.224 0.097 CID_50591 0.338 0.045 CID_524508 | CID_524508 | |
| 0.247 | 0.015 | 0.442 | Cyclin-dependent kinase 5 inhibitor | 0.442 0.005 CID_321710 0.439 0.005 CID_50591 0.182 0.027 CID_524508 | CID_321710 | |
| 0.238 | 0.008 | 0.238 | Janus tyrosine kinase 3 inhibitor | 0.081 0.044 CID_524508 | ||
| 0.237 | 0.009 | 0.362 | Beta glucuronidase inhibitor | 0.132 0.036 CID_321710 0.234 0.009 CID_50591 0.362 0.005 CID_524508 | CID_524508 | |
| 0.231 | 0.009 | 0.231 | 5 Hydroxytryptamine 1F antagonist | 0.167 0.014 CID_321710 0.06 0.059 CID_50591 0.075 0.046 CID_524508 | ||
| 0.231 | 0.01 | 0.231 | Protein kinase A inhibitor | 0.08 0.06 CID_321710 0.172 0.019 CID_524508 | ||
| 0.24 | 0.02 | 0.336 | Aldehyde dehydrogenase inhibitor | 0.163 0.04 CID_321710 0.196 0.029 CID_50591 0.336 0.009 CID_524508 | CID_524508 | |
| 0.225 | 0.005 | 0.225 | MAP-kinase-activated kinase inhibitor | 0.128 0.022 CID_321710 0.151 0.015 CID_524508 | ||
| 0.224 | 0.005 | 0.247 | Prolactin inhibitor | 0.177 0.013 CID_321710 0.247 0.004 CID_50591 0.235 0.005 CID_524508 | CID_50591 | |
| 0.239 | 0.03 | 0.274 | Glycogen synthase kinase-3 alpha inhibitor | 0.274 0.021 CID_321710 0.144 0.071 CID_50591 0.222 0.035 CID_524508 | CID_321710 | |
| 0.215 | 0.01 | 0.215 | MAP3K9 inhibitor | 0.182 0.025 CID_321710 0.168 0.037 CID_50591 0.19 0.02 CID_524508 | ||
| 0.23 | 0.026 | 0.263 | Alpha-N-acetylglucosaminidase inhibitor | 0.263 0.021 CID_321710 0.231 0.026 CID_50591 0.203 0.033 CID_524508 | CID_321710 | |
| 0.205 | 0.004 | 0.205 | 5 Hydroxytryptamine 7 agonist | 0.192 0.004 CID_321710 0.074 0.016 CID_50591 0.171 0.004 CID_524508 | ||
| 0.211 | 0.01 | 0.238 | Interleukin 8 antagonist | 0.109 0.077 CID_321710 0.165 0.025 CID_50591 0.238 0.007 CID_524508 | CID_524508 | |
| 0.203 | 0.005 | 0.203 | MAP-kinase-activated kinase 2 inhibitor | 0.119 0.02 CID_321710 0.137 0.014 CID_524508 | ||
| 0.209 | 0.014 | 0.209 | 5 Hydroxytryptamine agonist | 0.11 0.03 CID_321710 0.13 0.025 CID_50591 | ||
| 0.207 | 0.013 | 0.207 | Activin receptor-like kinase 4 inhibitor | 0.111 0.065 CID_524508 | ||
| 0.207 | 0.013 | 0.207 | Pim-1 kinase inhibitor | 0.13 0.036 CID_524508 | ||
| 0.206 | 0.015 | 0.213 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.213 0.013 CID_321710 0.163 0.051 CID_50591 0.192 0.023 CID_524508 | CID_321710 | |
| 0.207 | 0.016 | 0.207 | GABA receptor agonist | 0.121 0.056 CID_321710 0.139 0.043 CID_50591 0.146 0.038 CID_524508 | ||
| 0.215 | 0.029 | 0.261 | Neurotensin receptor agonist | 0.181 0.048 CID_321710 0.204 0.033 CID_50591 0.261 0.019 CID_524508 | CID_524508 | |
| 0.197 | 0.012 | 0.197 | Rho-associated kinase II inhibitor | |||
| 0.246 | 0.06 | 0.337 | Psychostimulant | 0.337 0.034 CID_321710 0.194 0.083 CID_50591 0.233 0.065 CID_524508 | CID_321710 | |
| 0.234 | 0.05 | 0.285 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.285 0.033 CID_321710 0.215 0.061 CID_524508 | CID_321710 | |
| 0.224 | 0.041 | 0.224 | Histone acetyltransferase inhibitor | 0.192 0.082 CID_321710 0.175 0.106 CID_50591 0.211 0.053 CID_524508 | ||
| 0.212 | 0.029 | 0.277 | Glycogen synthase kinase-3 inhibitor | 0.277 0.018 CID_321710 0.127 0.057 CID_50591 0.102 0.078 CID_524508 | CID_321710 | |
| 0.214 | 0.032 | 0.214 | Ribosomal protein S6 kinase inhibitor | 0.164 0.056 CID_524508 | ||
| 0.2 | 0.019 | 0.2 | Interleukin 1b antagonist | 0.16 0.034 CID_524508 | ||
| 0.209 | 0.033 | 0.209 | Activin receptor-like kinase 2 inhibitor | 0.202 0.036 CID_321710 0.113 0.106 CID_50591 0.164 0.057 CID_524508 | ||
| 0.197 | 0.02 | 0.197 | Nav1.6 sodium channel blocker | 0.188 0.024 CID_321710 0.142 0.063 CID_50591 0.153 0.05 CID_524508 | ||
| 0.203 | 0.028 | 0.203 | Protein kinase (CK1) delta inhibitor | |||
| 0.228 | 0.053 | 0.261 | Neurotrophic factor enhancer | 0.224 0.056 CID_321710 0.242 0.043 CID_50591 0.261 0.033 CID_524508 | CID_524508 | |
| 0.188 | 0.013 | 0.188 | Janus tyrosine kinase 2 inhibitor | |||
| 0.192 | 0.018 | 0.241 | Polo-like kinase-4 inhibitor | 0.241 0.009 CID_321710 0.139 0.043 CID_524508 | CID_321710 | |
| 0.206 | 0.032 | 0.206 | Cyclin-dependent kinase 8 inhibitor | 0.194 0.04 CID_321710 0.122 0.115 CID_50591 0.174 0.057 CID_524508 | ||
| 0.205 | 0.033 | 0.262 | NADPH oxidase inhibitor | 0.231 0.025 CID_321710 0.171 0.044 CID_50591 0.262 0.018 CID_524508 | CID_524508 | |
| 0.175 | 0.005 | 0.175 | Protein kinase C eta inhibitor | 0.076 0.025 CID_321710 0.096 0.018 CID_50591 0.155 0.007 CID_524508 | ||
| 0.23 | 0.06 | 0.29 | DNA methylase inhibitor | 0.147 0.12 CID_321710 0.271 0.038 CID_50591 0.29 0.031 CID_524508 | CID_524508 | |
| 0.172 | 0.003 | 0.176 | Cyclin D1 inhibitor | 0.075 0.022 CID_321710 0.094 0.01 CID_50591 0.176 0.003 CID_524508 | CID_524508 | |
| 0.18 | 0.011 | 0.18 | Pim-3 kinase inhibitor | 0.092 0.056 CID_321710 0.092 0.055 CID_50591 0.133 0.024 CID_524508 | ||
| 0.203 | 0.035 | 0.226 | ATPase inhibitor | 0.226 0.021 CID_321710 0.178 0.061 CID_50591 0.214 0.027 CID_524508 | CID_321710 | |
| 0.201 | 0.035 | 0.201 | Toll-Like receptor 9 antagonist | 0.136 0.072 CID_321710 0.168 0.052 CID_524508 | ||
| 0.186 | 0.02 | 0.193 | MAP kinase kinase 4 inhibitor | 0.143 0.077 CID_321710 0.178 0.026 CID_50591 0.193 0.017 CID_524508 | CID_524508 | |
| 0.172 | 0.009 | 0.172 | Histamine N-methyltransferase inhibitor | 0.125 0.027 CID_321710 0.157 0.012 CID_50591 0.145 0.016 CID_524508 | ||
| 0.174 | 0.011 | 0.174 | Acetylcholine nicotinic agonist | 0.096 0.04 CID_321710 0.071 0.07 CID_50591 0.128 0.024 CID_524508 | ||
| 0.206 | 0.044 | 0.206 | Protein-tyrosine kinase Lyn inhibitor | 0.121 0.084 CID_50591 0.107 0.095 CID_524508 | ||
| 0.191 | 0.028 | 0.191 | MAP kinase 3 inhibitor | 0.161 0.053 CID_321710 0.165 0.047 CID_524508 | ||
| 0.321 | 0.159 | 0.321 | MAP kinase 1 inhibitor | 0.246 0.238 CID_321710 0.3 0.18 CID_524508 | ||
| 0.189 | 0.026 | 0.242 | Alpha 2b adrenoreceptor antagonist | 0.242 0.016 CID_321710 0.122 0.057 CID_50591 0.157 0.036 CID_524508 | CID_321710 | |
| 0.18 | 0.018 | 0.18 | Adenylate kinase inhibitor | 0.136 0.033 CID_321710 0.178 0.019 CID_50591 0.155 0.025 CID_524508 | ||
| 0.213 | 0.052 | 0.213 | Growth factor agonist | 0.201 0.062 CID_524508 | ||
| 0.191 | 0.031 | 0.271 | Glycogen synthase kinase-3 beta inhibitor | 0.271 0.017 CID_321710 0.134 0.052 CID_50591 0.1 0.078 CID_524508 | CID_321710 | |
| 0.198 | 0.038 | 0.245 | Cyclin-dependent kinase inhibitor | 0.238 0.029 CID_321710 0.245 0.028 CID_50591 0.104 0.086 CID_524508 | CID_50591 | |
| 0.171 | 0.012 | 0.177 | Ca2+-transporting ATPase inhibitor | 0.163 0.02 CID_321710 0.177 0.008 CID_50591 0.167 0.016 CID_524508 | CID_50591 | |
| 0.172 | 0.016 | 0.327 | Creatine kinase inhibitor | 0.144 0.026 CID_321710 0.248 0.005 CID_50591 0.327 0.004 CID_524508 | CID_524508 | |
| 0.207 | 0.052 | 0.277 | Lipocortins synthesis antagonist | 0.277 0.026 CID_321710 0.221 0.045 CID_50591 0.179 0.072 CID_524508 | CID_321710 | |
| 0.171 | 0.018 | 0.171 | Death-associated protein kinase 1 inhibitor | 0.165 0.022 CID_321710 0.127 0.091 CID_50591 0.136 0.065 CID_524508 | ||
| 0.165 | 0.011 | 0.166 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.09 0.049 CID_321710 0.104 0.034 CID_50591 0.166 0.011 CID_524508 | CID_524508 | |
| 0.214 | 0.061 | 0.273 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.203 0.069 CID_321710 0.219 0.058 CID_50591 0.273 0.033 CID_524508 | CID_524508 | |
| 0.161 | 0.009 | 0.161 | Protein kinase C alpha inhibitor | 0.061 0.059 CID_321710 0.101 0.022 CID_524508 | ||
| 0.173 | 0.02 | 0.178 | Photosensitizer | 0.156 0.028 CID_321710 0.151 0.03 CID_50591 0.178 0.019 CID_524508 | CID_524508 | |
| 0.239 | 0.087 | 0.318 | Interleukin agonist | 0.318 0.04 CID_321710 0.21 0.112 CID_50591 0.198 0.123 CID_524508 | CID_321710 | |
| 0.174 | 0.022 | 0.219 | UDP-glucose 4-epimerase inhibitor | 0.18 0.021 CID_321710 0.219 0.016 CID_50591 0.182 0.021 CID_524508 | CID_50591 | |
| 0.156 | 0.005 | 0.156 | Bromodomain-containing protein 4 inhibitor | 0.082 0.018 CID_524508 | ||
| 0.162 | 0.014 | 0.162 | CDC-like kinase 3 inhibitor | 0.105 0.069 CID_50591 0.144 0.021 CID_524508 | ||
| 0.167 | 0.02 | 0.17 | Heat shock protein 70 antagonist | 0.15 0.045 CID_321710 0.162 0.025 CID_50591 0.17 0.018 CID_524508 | CID_524508 | |
| 0.154 | 0.008 | 0.154 | Bromodomain-containing protein 2 inhibitor | 0.135 0.015 CID_321710 0.092 0.051 CID_50591 0.117 0.025 CID_524508 | ||
| 0.163 | 0.017 | 0.163 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.103 0.034 CID_321710 0.138 0.022 CID_524508 | ||
| 0.177 | 0.032 | 0.177 | Vascular endothelial growth factor 1 antagonist | 0.094 0.07 CID_524508 | ||
| 0.229 | 0.084 | 0.282 | DNA synthesis inhibitor | 0.219 0.095 CID_321710 0.282 0.05 CID_50591 0.259 0.061 CID_524508 | CID_50591 | |
| 0.151 | 0.008 | 0.151 | Benzodiazepine agonist | 0.132 0.012 CID_321710 0.071 0.049 CID_50591 0.081 0.038 CID_524508 | ||
| 0.176 | 0.034 | 0.244 | MAO A inhibitor | 0.119 0.053 CID_321710 0.111 0.057 CID_50591 0.244 0.022 CID_524508 | CID_524508 | |
| 0.173 | 0.032 | 0.173 | Antibacterial (Helicobacter pylori) | 0.143 0.052 CID_50591 0.168 0.034 CID_524508 | ||
| 0.169 | 0.028 | 0.169 | Falcipain 3 inhibitor | 0.161 0.032 CID_321710 0.15 0.037 CID_50591 0.133 0.045 CID_524508 | ||
| 0.144 | 0.005 | 0.144 | Protein kinase C beta inhibitor | 0.122 0.007 CID_321710 0.106 0.011 CID_50591 0.129 0.005 CID_524508 | ||
| 0.193 | 0.055 | 0.218 | Succinate dehydrogenase inhibitor | 0.206 0.044 CID_321710 0.218 0.036 CID_50591 0.204 0.046 CID_524508 | CID_50591 | |
| 0.171 | 0.033 | 0.277 | Cystathionine beta-synthase inhibitor | 0.124 0.055 CID_321710 0.192 0.026 CID_50591 0.277 0.012 CID_524508 | CID_524508 | |
| 0.15 | 0.012 | 0.15 | 5 Hydroxytryptamine 1D antagonist | 0.117 0.017 CID_321710 0.072 0.037 CID_524508 | ||
| 0.167 | 0.029 | 0.167 | Pregnane X receptor agonist | 0.147 0.058 CID_321710 0.134 0.089 CID_50591 0.147 0.058 CID_524508 | ||
| 0.143 | 0.006 | 0.148 | Granulocyte macrophage colony stimulating factor agonist | 0.13 0.011 CID_321710 0.148 0.005 CID_50591 0.141 0.007 CID_524508 | CID_50591 | |
| 0.261 | 0.124 | 0.279 | Vasodilator, coronary | 0.279 0.105 CID_321710 0.231 0.153 CID_50591 0.265 0.119 CID_524508 | CID_321710 | |
| 0.144 | 0.007 | 0.144 | Protein kinase C epsilon inhibitor | 0.089 0.016 CID_524508 | ||
| 0.141 | 0.005 | 0.171 | GABA B receptor agonist | 0.098 0.018 CID_321710 0.15 0.004 CID_50591 0.171 0.004 CID_524508 | CID_524508 | |
| 0.159 | 0.022 | 0.215 | HIV-1 integrase (Overall Integration) inhibitor | 0.124 0.037 CID_321710 0.215 0.009 CID_50591 0.152 0.025 CID_524508 | CID_50591 | |
| 0.139 | 0.004 | 0.139 | 5 Hydroxytryptamine 1B agonist | 0.081 0.012 CID_321710 0.069 0.018 CID_50591 0.071 0.017 CID_524508 | ||
| 0.143 | 0.009 | 0.143 | Protein kinase B beta inhibitor | 0.072 0.054 CID_524508 | ||
| 0.168 | 0.035 | 0.168 | Cathepsin H inhibitor | 0.146 0.049 CID_321710 0.133 0.061 CID_50591 0.121 0.074 CID_524508 | ||
| 0.161 | 0.028 | 0.161 | Check point kinase 2 inhibitor | 0.123 0.046 CID_321710 0.113 0.054 CID_524508 | ||
| 0.143 | 0.011 | 0.326 | Alcohol oxidase inhibitor | 0.102 0.018 CID_321710 0.175 0.008 CID_50591 0.326 0.004 CID_524508 | CID_524508 | |
| 0.168 | 0.037 | 0.186 | Adenylate cyclase stimulant | 0.174 0.031 CID_321710 0.186 0.021 CID_50591 0.185 0.022 CID_524508 | CID_50591 | |
| 0.15 | 0.019 | 0.15 | MAP kinase 14 inhibitor | |||
| 0.141 | 0.01 | 0.141 | Protein kinase C iota inhibitor | 0.089 0.022 CID_50591 0.076 0.028 CID_524508 | ||
| 0.164 | 0.033 | 0.164 | Cyclin-dependent kinase 2 inhibitor | 0.113 0.058 CID_321710 0.098 0.072 CID_50591 0.093 0.078 CID_524508 | ||
| 0.14 | 0.01 | 0.222 | Glycine receptor antagonist | 0.222 0.003 CID_321710 0.134 0.012 CID_50591 0.115 0.021 CID_524508 | CID_321710 | |
| 0.146 | 0.016 | 0.146 | GABA A receptor agonist | 0.093 0.044 CID_50591 0.095 0.043 CID_524508 | ||
| 0.148 | 0.021 | 0.152 | Triose-phosphate isomerase inhibitor | 0.136 0.025 CID_321710 0.152 0.019 CID_50591 0.135 0.025 CID_524508 | CID_50591 | |
| 0.129 | 0.004 | 0.129 | Glutamate (mGluR1a) antagonist | 0.062 0.014 CID_321710 0.044 0.025 CID_524508 | ||
| 0.181 | 0.056 | 0.181 | Cytidine deaminase inhibitor | 0.16 0.068 CID_321710 | ||
| 0.14 | 0.016 | 0.14 | Check point kinase 1 inhibitor | 0.096 0.03 CID_321710 0.13 0.018 CID_524508 | ||
| 0.146 | 0.022 | 0.204 | Carbonic anhydrase VI inhibitor | 0.099 0.04 CID_321710 0.131 0.026 CID_50591 0.204 0.013 CID_524508 | CID_524508 | |
| 0.156 | 0.032 | 0.156 | Cyclin-dependent kinase 9 inhibitor | 0.106 0.056 CID_321710 0.127 0.042 CID_50591 0.121 0.045 CID_524508 | ||
| 0.167 | 0.044 | 0.167 | Sodium channel (voltage-gated) blocker | |||
| 0.169 | 0.046 | 0.169 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.106 0.076 CID_524508 | ||
| 0.271 | 0.149 | 0.357 | 15-Lipoxygenase inhibitor | 0.274 0.147 CID_321710 0.304 0.129 CID_50591 0.357 0.096 CID_524508 | CID_524508 | |
| 0.141 | 0.019 | 0.141 | Protein kinase B gamma inhibitor | |||
| 0.151 | 0.029 | 0.151 | MAP kinase 8 inhibitor | |||
| 0.128 | 0.006 | 0.128 | CC chemokine 5 receptor agonist | 0.107 0.015 CID_321710 0.126 0.007 CID_50591 0.128 0.006 CID_524508 | ||
| 0.159 | 0.038 | 0.449 | Cyclin-dependent kinase 1 inhibitor | 0.357 0.008 CID_321710 0.449 0.005 CID_50591 0.104 0.064 CID_524508 | CID_50591 | |
| 0.246 | 0.126 | 0.311 | Angiogenesis inhibitor | 0.281 0.103 CID_321710 0.311 0.087 CID_524508 | CID_524508 | |
| 0.177 | 0.057 | 0.206 | Interleukin 6 antagonist | 0.131 0.123 CID_50591 0.206 0.037 CID_524508 | CID_524508 | |
| 0.126 | 0.005 | 0.148 | Fatty acid synthase inhibitor | 0.094 0.013 CID_321710 0.095 0.012 CID_50591 0.148 0.005 CID_524508 | CID_524508 | |
| 0.13 | 0.01 | 0.13 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 CID_321710 0.111 0.012 CID_50591 0.095 0.015 CID_524508 | ||
| 0.134 | 0.013 | 0.134 | Protein kinase B alpha inhibitor | 0.062 0.059 CID_524508 | ||
| 0.147 | 0.027 | 0.184 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.184 0.019 CID_321710 0.144 0.028 CID_50591 0.11 0.046 CID_524508 | CID_321710 | |
| 0.124 | 0.005 | 0.125 | Phospholipase D inhibitor | 0.125 0.005 CID_321710 0.091 0.021 CID_50591 0.086 0.026 CID_524508 | CID_321710 | |
| 0.139 | 0.019 | 0.139 | I kappa B kinase inhibitor | 0.082 0.058 CID_50591 0.126 0.024 CID_524508 | ||
| 0.124 | 0.004 | 0.124 | GABA B receptor antagonist | 0.057 0.014 CID_321710 0.065 0.01 CID_50591 0.086 0.005 CID_524508 | ||
| 0.165 | 0.046 | 0.165 | Toll-Like receptor antagonist | 0.108 0.105 CID_321710 0.155 0.052 CID_524508 | ||
| 0.169 | 0.05 | 0.193 | Mannose-6-phosphate isomerase inhibitor | 0.156 0.059 CID_321710 0.193 0.034 CID_50591 0.144 0.07 CID_524508 | CID_50591 | |
| 0.145 | 0.027 | 0.145 | Transcription factor STAT6 inhibitor | 0.11 0.08 CID_321710 0.115 0.069 CID_50591 0.137 0.035 CID_524508 | ||
| 0.154 | 0.036 | 0.154 | MAP kinase 9 inhibitor | |||
| 0.172 | 0.055 | 0.196 | Hexokinase inhibitor | 0.194 0.039 CID_321710 0.176 0.052 CID_50591 0.196 0.038 CID_524508 | CID_524508 | |
| 0.124 | 0.008 | 0.124 | 5 Hydroxytryptamine 3 agonist | 0.076 0.03 CID_321710 0.092 0.019 CID_50591 0.092 0.019 CID_524508 | ||
| 0.14 | 0.024 | 0.151 | Electrolyte absorption antagonist | 0.151 0.019 CID_321710 0.11 0.045 CID_50591 0.103 0.054 CID_524508 | CID_321710 | |
| 0.129 | 0.013 | 0.129 | CDC7 inhibitor | 0.104 0.022 CID_321710 0.085 0.032 CID_50591 0.077 0.038 CID_524508 | ||
| 0.181 | 0.066 | 0.184 | Tumour necrosis factor antagonist | 0.184 0.064 CID_321710 0.183 0.064 CID_524508 | CID_321710 | |
| 0.141 | 0.026 | 0.195 | DOPA decarboxylase inhibitor | 0.128 0.037 CID_321710 0.176 0.011 CID_50591 0.195 0.007 CID_524508 | CID_524508 | |
| 0.214 | 0.1 | 0.214 | Calpain inhibitor | 0.186 0.128 CID_321710 0.17 0.149 CID_50591 0.169 0.149 CID_524508 | ||
| 0.16 | 0.046 | 0.2 | Toll-Like receptor 2 antagonist | 0.112 0.087 CID_321710 0.2 0.023 CID_50591 0.195 0.026 CID_524508 | CID_50591 | |
| 0.128 | 0.014 | 0.128 | mTOR complex 2 inhibitor | 0.087 0.053 CID_321710 0.084 0.06 CID_50591 0.111 0.023 CID_524508 | ||
| 0.121 | 0.008 | 0.121 | Aryl hydrocarbon receptor antagonist | 0.059 0.055 CID_321710 0.081 0.025 CID_50591 0.098 0.014 CID_524508 | ||
| 0.123 | 0.011 | 0.123 | 5 Hydroxytryptamine 5 antagonist | 0.076 0.022 CID_321710 0.06 0.036 CID_50591 0.069 0.027 CID_524508 | ||
| 0.159 | 0.047 | 0.188 | MAP kinase kinase inhibitor | 0.127 0.067 CID_321710 0.188 0.033 CID_524508 | CID_524508 | |
| 0.131 | 0.019 | 0.131 | Alpha adrenoreceptor agonist | 0.103 0.027 CID_321710 0.065 0.05 CID_50591 0.125 0.021 CID_524508 | ||
| 0.123 | 0.011 | 0.123 | 5 Hydroxytryptamine 5A antagonist | 0.088 0.02 CID_321710 0.067 0.034 CID_50591 0.077 0.025 CID_524508 | ||
| 0.14 | 0.028 | 0.14 | Catalase inhibitor | 0.078 0.048 CID_321710 0.092 0.041 CID_50591 0.117 0.034 CID_524508 | ||
| 0.133 | 0.021 | 0.133 | Toll-Like receptor 3 antagonist | 0.104 0.045 CID_50591 | ||
| 0.129 | 0.018 | 0.129 | Nav1.8 sodium channel blocker | 0.076 0.048 CID_524508 | ||
| 0.12 | 0.01 | 0.12 | Alpha 2 adrenoreceptor agonist | 0.088 0.019 CID_321710 0.06 0.042 CID_50591 0.101 0.014 CID_524508 | ||
| 0.155 | 0.045 | 0.155 | Nav1.3 sodium channel blocker | |||
| 0.114 | 0.005 | 0.134 | MAP kinase kinase 7 inhibitor | 0.099 0.014 CID_321710 0.11 0.007 CID_50591 0.134 0.003 CID_524508 | CID_524508 | |
| 0.115 | 0.007 | 0.115 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.092 0.02 CID_321710 0.093 0.019 CID_50591 0.088 0.025 CID_524508 | ||
| 0.149 | 0.041 | 0.174 | 5 Hydroxytryptamine 2B antagonist | 0.174 0.032 CID_321710 0.109 0.072 CID_524508 | CID_321710 | |
| 0.124 | 0.016 | 0.124 | 5 Hydroxytryptamine 1B antagonist | 0.116 0.018 CID_321710 0.063 0.048 CID_524508 | ||
| 0.135 | 0.029 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 CID_321710 0.102 0.082 CID_50591 | CID_321710 | |
| 0.129 | 0.023 | 0.129 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 CID_321710 0.11 0.042 CID_50591 0.114 0.037 CID_524508 | ||
| 0.148 | 0.043 | 0.15 | Protein kinase (CK2) alpha inhibitor | 0.127 0.058 CID_321710 0.094 0.082 CID_50591 0.15 0.042 CID_524508 | CID_524508 | |
| 0.138 | 0.034 | 0.239 | Carbonic anhydrase III inhibitor | 0.126 0.04 CID_321710 0.173 0.022 CID_50591 0.239 0.01 CID_524508 | CID_524508 | |
| 0.11 | 0.006 | 0.11 | Glutamate (mGluR7) antagonist | 0.09 0.017 CID_321710 0.09 0.017 CID_50591 0.1 0.01 CID_524508 | ||
| 0.152 | 0.049 | 0.163 | 5 Hydroxytryptamine antagonist | 0.163 0.044 CID_321710 | CID_321710 | |
| 0.116 | 0.013 | 0.116 | GABA receptor antagonist | 0.076 0.023 CID_321710 0.06 0.032 CID_50591 0.073 0.024 CID_524508 | ||
| 0.118 | 0.015 | 0.141 | D-Ala-D-Ala ligase inhibitor | 0.094 0.037 CID_321710 0.129 0.01 CID_50591 0.141 0.007 CID_524508 | CID_524508 | |
| 0.151 | 0.049 | 0.151 | Aurora-C kinase inhibitor | 0.141 0.063 CID_321710 0.13 0.082 CID_524508 | ||
| 0.115 | 0.013 | 0.115 | GABA A receptor antagonist | 0.074 0.024 CID_321710 0.058 0.032 CID_50591 0.069 0.026 CID_524508 | ||
| 0.112 | 0.012 | 0.112 | 5 Hydroxytryptamine 6 antagonist | 0.052 0.046 CID_321710 0.052 0.045 CID_524508 | ||
| 0.134 | 0.034 | 0.134 | Gastric antisecretory | 0.103 0.063 CID_50591 0.116 0.046 CID_524508 | ||
| 0.12 | 0.021 | 0.12 | Rho-associated kinase I inhibitor | 0.065 0.063 CID_524508 | ||
| 0.144 | 0.045 | 0.144 | Beta amyloid protein antagonist | 0.124 0.063 CID_524508 | ||
| 0.216 | 0.117 | 0.216 | Transcription factor STAT inhibitor | 0.216 0.117 CID_524508 | ||
| 0.108 | 0.011 | 0.108 | Nicotinic neuronal receptor agonist | 0.061 0.035 CID_321710 0.063 0.033 CID_524508 | ||
| 0.109 | 0.012 | 0.137 | Beta 3 adrenoreceptor antagonist | 0.101 0.014 CID_321710 0.102 0.014 CID_50591 0.137 0.007 CID_524508 | CID_524508 | |
| 0.136 | 0.039 | 0.139 | Protein kinase (CK2) inhibitor | 0.123 0.046 CID_321710 0.087 0.076 CID_50591 0.139 0.038 CID_524508 | CID_524508 | |
| 0.11 | 0.013 | 0.111 | Bcl2 antagonist | 0.111 0.013 CID_524508 | CID_524508 | |
| 0.12 | 0.026 | 0.231 | Histidine decarboxylase inhibitor | 0.076 0.045 CID_321710 0.175 0.016 CID_50591 0.231 0.01 CID_524508 | CID_524508 | |
| 0.164 | 0.07 | 0.164 | Polo-like kinase-3 inhibitor | 0.134 0.104 CID_524508 | ||
| 0.153 | 0.06 | 0.187 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.155 0.058 CID_321710 0.187 0.045 CID_524508 | CID_524508 | |
| 0.11 | 0.017 | 0.11 | Transforming growth factor antagonist | |||
| 0.118 | 0.025 | 0.118 | Alpha 2d adrenoreceptor antagonist | 0.098 0.051 CID_50591 0.089 0.074 CID_524508 | ||
| 0.133 | 0.041 | 0.177 | Alpha 2c adrenoreceptor antagonist | 0.177 0.023 CID_321710 0.116 0.052 CID_524508 | CID_321710 | |
| 0.135 | 0.043 | 0.16 | TRPA1 agonist | 0.16 0.025 CID_321710 0.138 0.04 CID_50591 0.13 0.047 CID_524508 | CID_321710 | |
| 0.105 | 0.014 | 0.105 | Pim-2 kinase inhibitor | 0.058 0.033 CID_524508 | ||
| 0.123 | 0.032 | 0.129 | MAP kinase kinase 1 inhibitor | 0.09 0.071 CID_321710 0.129 0.027 CID_524508 | CID_524508 | |
| 0.175 | 0.083 | 0.264 | DNA methyltransferase I inhibitor | 0.151 0.103 CID_321710 0.188 0.076 CID_50591 0.264 0.041 CID_524508 | CID_524508 | |
| 0.113 | 0.022 | 0.113 | Nicotinic alpha4beta2 receptor antagonist | 0.07 0.062 CID_321710 0.071 0.061 CID_50591 0.085 0.045 CID_524508 | ||
| 0.101 | 0.01 | 0.101 | Nicotinic alpha7 receptor agonist | 0.06 0.032 CID_321710 | ||
| 0.103 | 0.013 | 0.161 | 5 Hydroxytryptamine 2A agonist | 0.161 0.005 CID_321710 0.097 0.016 CID_50591 0.096 0.016 CID_524508 | CID_321710 | |
| 0.113 | 0.023 | 0.113 | Tyk2 inhibitor | |||
| 0.109 | 0.02 | 0.109 | Janus tyrosine kinase 1 inhibitor | |||
| 0.103 | 0.014 | 0.103 | Potassium channel (ATP-sensitive) blocker | 0.068 0.045 CID_50591 0.097 0.017 CID_524508 | ||
| 0.107 | 0.02 | 0.107 | Polo-like kinase-2 inhibitor | 0.074 0.05 CID_524508 | ||
| 0.116 | 0.031 | 0.13 | NADH dehydrogenase inhibitor | 0.121 0.028 CID_321710 0.13 0.024 CID_50591 0.123 0.027 CID_524508 | CID_50591 | |
| 0.202 | 0.116 | 0.254 | Neuropeptide Y2 antagonist | 0.254 0.053 CID_321710 0.182 0.156 CID_50591 0.177 0.167 CID_524508 | CID_321710 | |
| 0.095 | 0.009 | 0.095 | Aconitate hydratase inhibitor | 0.07 0.019 CID_321710 0.075 0.016 CID_50591 0.069 0.019 CID_524508 | ||
| 0.092 | 0.007 | 0.092 | Potassium channel small-conductance Ca-activated blocker | 0.04 0.039 CID_321710 0.043 0.034 CID_50591 | ||
| 0.148 | 0.064 | 0.148 | Sphingosine 1-phosphate receptor 5 antagonist | 0.144 0.072 CID_321710 0.136 0.087 CID_50591 0.142 0.076 CID_524508 | ||
| 0.089 | 0.004 | 0.089 | Alpha 1d adrenoreceptor agonist | 0.05 0.016 CID_321710 0.069 0.008 CID_50591 0.072 0.007 CID_524508 | ||
| 0.16 | 0.076 | 0.179 | Arachidonic acid antagonist | 0.156 0.082 CID_321710 0.179 0.054 CID_50591 0.173 0.062 CID_524508 | CID_50591 | |
| 0.088 | 0.004 | 0.088 | Protein kinase (CK1) epsilon inhibitor | 0.039 0.027 CID_524508 | ||
| 0.097 | 0.014 | 0.097 | I kappa B kinase 2 inhibitor | 0.056 0.055 CID_321710 0.066 0.037 CID_50591 0.087 0.018 CID_524508 | ||
| 0.127 | 0.043 | 0.147 | AMP-activated protein kinase stimulant | 0.112 0.056 CID_321710 0.123 0.046 CID_50591 0.147 0.03 CID_524508 | CID_524508 | |
| 0.119 | 0.036 | 0.119 | 5 Hydroxytryptamine 2C antagonist | 0.105 0.043 CID_321710 | ||
| 0.14 | 0.058 | 0.14 | Vascular endothelial growth factor antagonist | 0.102 0.08 CID_524508 | ||
| 0.086 | 0.006 | 0.086 | Histamine H2 receptor agonist | 0.054 0.018 CID_321710 0.044 0.029 CID_50591 0.046 0.026 CID_524508 | ||
| 0.09 | 0.01 | 0.09 | Histone deacetylase 7 inhibitor | 0.043 0.021 CID_321710 0.034 0.029 CID_50591 0.041 0.022 CID_524508 | ||
| 0.144 | 0.064 | 0.179 | Alkaline phosphatase inhibitor | 0.135 0.071 CID_50591 0.179 0.043 CID_524508 | CID_524508 | |
| 0.127 | 0.047 | 0.127 | MAP kinase kinase kinase inhibitor | |||
| 0.112 | 0.033 | 0.125 | 5 Hydroxytryptamine 1 antagonist | 0.125 0.029 CID_321710 | CID_321710 | |
| 0.102 | 0.023 | 0.149 | Cyclin E inhibitor | 0.149 0.01 CID_50591 0.052 0.047 CID_524508 | CID_50591 | |
| 0.089 | 0.01 | 0.089 | Nicotinic alpha3beta2 receptor antagonist | 0.06 0.026 CID_321710 0.059 0.027 CID_50591 0.053 0.036 CID_524508 | ||
| 0.126 | 0.047 | 0.134 | Nav1.4 sodium channel blocker | 0.106 0.068 CID_50591 0.134 0.041 CID_524508 | CID_524508 | |
| 0.127 | 0.049 | 0.127 | Aminopeptidase B inhibitor | 0.126 0.049 CID_321710 0.117 0.054 CID_50591 0.125 0.05 CID_524508 | ||
| 0.086 | 0.008 | 0.114 | CDK5/p25 inhibitor | 0.114 0.005 CID_321710 0.05 0.021 CID_50591 0.086 0.008 CID_524508 | CID_321710 | |
| 0.121 | 0.044 | 0.13 | Urease inhibitor | 0.102 0.064 CID_321710 0.128 0.038 CID_50591 0.13 0.036 CID_524508 | CID_524508 | |
| 0.087 | 0.009 | 0.087 | Growth hormone secretagogue receptor antagonist | |||
| 0.095 | 0.018 | 0.173 | Glutamate (mGluR1) antagonist | 0.173 0.005 CID_321710 | CID_321710 | |
| 0.122 | 0.045 | 0.154 | Carbonic anhydrase XV inhibitor | 0.091 0.081 CID_321710 0.133 0.038 CID_50591 0.154 0.029 CID_524508 | CID_524508 | |
| 0.096 | 0.02 | 0.096 | Argininosuccinate synthase inhibitor | 0.087 0.023 CID_321710 0.093 0.021 CID_50591 0.078 0.026 CID_524508 | ||
| 0.099 | 0.024 | 0.099 | Transforming growth factor beta 3 antagonist | |||
| 0.08 | 0.005 | 0.08 | Cyclin E2 inhibitor | 0.036 0.014 CID_321710 0.037 0.014 CID_50591 0.068 0.005 CID_524508 | ||
| 0.114 | 0.039 | 0.181 | Hepatocyte growth factor antagonist | 0.181 0.014 CID_50591 0.119 0.036 CID_524508 | CID_50591 | |
| 0.088 | 0.014 | 0.088 | Toll-Like receptor 8 antagonist | |||
| 0.138 | 0.064 | 0.237 | Tubulin antagonist | 0.109 0.092 CID_50591 0.237 0.027 CID_524508 | CID_524508 | |
| 0.11 | 0.036 | 0.116 | Phosphodiesterase 6D inhibitor | 0.116 0.028 CID_321710 0.104 0.045 CID_50591 0.111 0.035 CID_524508 | CID_321710 | |
| 0.109 | 0.035 | 0.139 | Platelet growth factor antagonist | 0.139 0.022 CID_524508 | CID_524508 | |
| 0.142 | 0.068 | 0.225 | Amylase inhibitor | 0.18 0.051 CID_50591 0.225 0.036 CID_524508 | CID_524508 | |
| 0.13 | 0.057 | 0.13 | Aurora-B kinase inhibitor | 0.101 0.081 CID_524508 | ||
| 0.117 | 0.044 | 0.117 | Insulin receptor antagonist | 0.109 0.051 CID_321710 0.09 0.077 CID_524508 | ||
| 0.099 | 0.027 | 0.112 | Dopamine D4 antagonist | 0.112 0.023 CID_321710 0.058 0.044 CID_524508 | CID_321710 | |
| 0.087 | 0.015 | 0.087 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.043 CID_50591 0.063 0.026 CID_524508 | ||
| 0.088 | 0.016 | 0.088 | Cyclin-dependent kinase 6 inhibitor | 0.062 0.039 CID_321710 0.062 0.039 CID_524508 | ||
| 0.112 | 0.041 | 0.154 | Alcohol dehydrogenase inhibitor | 0.1 0.053 CID_321710 0.116 0.038 CID_50591 0.154 0.019 CID_524508 | CID_524508 | |
| 0.126 | 0.055 | 0.168 | 5 Hydroxytryptamine 2 antagonist | 0.168 0.038 CID_321710 | CID_321710 | |
| 0.078 | 0.007 | 0.096 | Purinergic P2X4 antagonist | 0.096 0.005 CID_321710 0.064 0.012 CID_50591 0.081 0.006 CID_524508 | CID_321710 | |
| 0.092 | 0.021 | 0.092 | Cyclin E1 inhibitor | |||
| 0.108 | 0.038 | 0.108 | Leucine-rich repeat kinase 2 inhibitor | 0.076 0.062 CID_321710 | ||
| 0.11 | 0.04 | 0.11 | Insulin growth factor antagonist | 0.094 0.051 CID_524508 | ||
| 0.102 | 0.033 | 0.112 | Somatostatin 1 agonist | 0.081 0.051 CID_321710 0.108 0.029 CID_50591 0.112 0.027 CID_524508 | CID_524508 | |
| 0.136 | 0.067 | 0.188 | MAO inhibitor | 0.131 0.069 CID_321710 0.188 0.044 CID_524508 | CID_524508 | |
| 0.073 | 0.004 | 0.073 | Histamine H1 receptor agonist | 0.059 0.009 CID_321710 0.051 0.016 CID_50591 0.043 0.031 CID_524508 | ||
| 0.082 | 0.014 | 0.082 | Transforming growth factor beta 1 antagonist | 0.046 0.039 CID_524508 | ||
| 0.09 | 0.023 | 0.09 | 5 Hydroxytryptamine 3A antagonist | 0.073 0.038 CID_321710 | ||
| 0.089 | 0.021 | 0.089 | Bombesin 1 receptor agonist | 0.072 0.03 CID_321710 0.065 0.035 CID_50591 0.062 0.039 CID_524508 | ||
| 0.136 | 0.069 | 0.136 | Sodium channel blocker | |||
| 0.094 | 0.027 | 0.094 | Neuronal nicotinic receptor antagonist | 0.082 0.035 CID_524508 | ||
| 0.108 | 0.041 | 0.176 | Androgen antagonist | 0.176 0.017 CID_321710 0.084 0.061 CID_50591 0.119 0.034 CID_524508 | CID_321710 | |
| 0.093 | 0.027 | 0.093 | MAP3K7 inhibitor | 0.075 0.047 CID_524508 | ||
| 0.073 | 0.008 | 0.091 | Inosine monophosphate dehydrogenase inhibitor | 0.062 0.01 CID_50591 0.091 0.005 CID_524508 | CID_524508 | |
| 0.098 | 0.033 | 0.12 | 5 Hydroxytryptamine 1A antagonist | 0.12 0.026 CID_321710 0.057 0.056 CID_524508 | CID_321710 | |
| 0.087 | 0.022 | 0.087 | TRPA1 antagonist | 0.078 0.027 CID_524508 | ||
| 0.083 | 0.018 | 0.09 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.064 0.036 CID_321710 0.059 0.045 CID_50591 0.09 0.014 CID_524508 | CID_524508 | |
| 0.082 | 0.018 | 0.106 | MDM2 inhibitor | 0.106 0.005 CID_321710 0.068 0.045 CID_50591 0.066 0.053 CID_524508 | CID_321710 | |
| 0.087 | 0.023 | 0.1 | Biliverdin reductase inhibitor | 0.1 0.018 CID_321710 0.077 0.028 CID_50591 0.067 0.035 CID_524508 | CID_321710 | |
| 0.093 | 0.029 | 0.093 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.077 | 0.013 | 0.077 | Prolactin release inhibitor | 0.073 0.018 CID_321710 0.075 0.016 CID_50591 0.071 0.02 CID_524508 | ||
| 0.11 | 0.046 | 0.11 | Nitric-oxide synthase inhibitor | 0.106 0.051 CID_321710 | ||
| 0.081 | 0.018 | 0.081 | Potassium channel (Ca-activated) blocker | |||
| 0.103 | 0.04 | 0.103 | Insulin like growth factor 1 antagonist | 0.085 0.055 CID_524508 | ||
| 0.17 | 0.107 | 0.485 | Anticonvulsant | 0.485 0.013 CID_321710 | CID_321710 | |
| 0.084 | 0.022 | 0.302 | NMDA 2C receptor antagonist | 0.302 0.004 CID_321710 0.093 0.018 CID_50591 0.107 0.014 CID_524508 | CID_321710 | |
| 0.072 | 0.01 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.06 0.024 CID_321710 0.067 0.013 CID_50591 0.064 0.017 CID_524508 | ||
| 0.105 | 0.043 | 0.126 | Acetylcholine agonist | 0.126 0.035 CID_321710 | CID_321710 | |
| 0.121 | 0.059 | 0.13 | Microtubule formation inhibitor | 0.115 0.066 CID_321710 0.111 0.072 CID_50591 0.13 0.051 CID_524508 | CID_524508 | |
| 0.081 | 0.02 | 0.15 | 5 Hydroxytryptamine 1A agonist | 0.039 0.038 CID_321710 0.15 0.011 CID_50591 | CID_50591 | |
| 0.103 | 0.041 | 0.103 | Phosphodiesterase I inhibitor | 0.095 0.052 CID_321710 0.091 0.056 CID_524508 | ||
| 0.091 | 0.03 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | 0.059 0.055 CID_321710 0.065 0.049 CID_524508 | ||
| 0.135 | 0.074 | 0.135 | Cytokine production inhibitor | |||
| 0.138 | 0.077 | 0.138 | Growth factor antagonist | 0.127 0.086 CID_524508 | ||
| 0.115 | 0.054 | 0.115 | Interleukin 2 antagonist | 0.113 0.057 CID_321710 | ||
| 0.1 | 0.039 | 0.1 | Acetylcholine nicotinic antagonist | 0.082 0.053 CID_524508 | ||
| 0.124 | 0.064 | 0.124 | TRKA antagonist | |||
| 0.078 | 0.019 | 0.114 | Corticotropin releasing factor 2 receptor antagonist | 0.114 0.005 CID_321710 | CID_321710 | |
| 0.09 | 0.03 | 0.09 | Cyclin-dependent kinase 4 inhibitor | 0.059 0.054 CID_50591 0.057 0.056 CID_524508 | ||
| 0.081 | 0.023 | 0.081 | Alpha 1 adrenoreceptor agonist | 0.067 0.029 CID_321710 0.071 0.027 CID_524508 | ||
| 0.212 | 0.154 | 0.275 | Cholesterol antagonist | 0.275 0.108 CID_321710 0.248 0.127 CID_50591 0.25 0.125 CID_524508 | CID_321710 | |
| 0.068 | 0.01 | 0.068 | Benzodiazepine inverse agonist | 0.057 0.017 CID_321710 0.045 0.037 CID_524508 | ||
| 0.089 | 0.032 | 0.31 | Dopamine agonist | 0.31 0.005 CID_321710 0.118 0.021 CID_524508 | CID_321710 | |
| 0.062 | 0.005 | 0.062 | ATR kinase inhibitor | 0.033 0.024 CID_321710 0.036 0.017 CID_524508 | ||
| 0.074 | 0.017 | 0.109 | 5 Hydroxytryptamine 2 agonist | 0.109 0.008 CID_321710 0.051 0.037 CID_524508 | CID_321710 | |
| 0.145 | 0.089 | 0.195 | Melanin inhibitor | 0.136 0.103 CID_321710 0.161 0.068 CID_50591 0.195 0.043 CID_524508 | CID_524508 | |
| 0.071 | 0.016 | 0.081 | Topoisomerase II beta inhibitor | 0.049 0.034 CID_321710 0.08 0.013 CID_50591 0.081 0.013 CID_524508 | CID_524508 | |
| 0.062 | 0.007 | 0.062 | 5 Hydroxytryptamine 1D agonist | |||
| 0.061 | 0.005 | 0.109 | Dopamine autoreceptor agonist | 0.109 0.004 CID_321710 0.037 0.01 CID_50591 0.082 0.004 CID_524508 | CID_321710 | |
| 0.105 | 0.05 | 0.165 | Glutamate (mGluR7) agonist | 0.165 0.008 CID_321710 | CID_321710 | |
| 0.065 | 0.01 | 0.065 | Histone deacetylase 9 inhibitor | 0.063 0.011 CID_321710 0.039 0.026 CID_50591 0.043 0.022 CID_524508 | ||
| 0.173 | 0.119 | 0.233 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.198 0.101 CID_321710 0.233 0.084 CID_50591 0.186 0.109 CID_524508 | CID_50591 | |
| 0.081 | 0.028 | 0.081 | MAP kinase kinase 10 inhibitor | 0.072 0.038 CID_321710 | ||
| 0.099 | 0.046 | 0.129 | Polo-like kinase-1 inhibitor | 0.129 0.026 CID_321710 0.089 0.064 CID_524508 | CID_321710 | |
| 0.122 | 0.069 | 0.138 | DNA repair enzyme inhibitor | 0.138 0.044 CID_321710 0.124 0.065 CID_50591 0.124 0.064 CID_524508 | CID_321710 | |
| 0.064 | 0.011 | 0.064 | Geranyltranstransferase inhibitor | 0.051 0.021 CID_50591 0.058 0.015 CID_524508 | ||
| 0.058 | 0.005 | 0.058 | Melatonin receptor 1A agonist | 0.035 0.021 CID_321710 0.041 0.013 CID_50591 0.035 0.019 CID_524508 | ||
| 0.064 | 0.011 | 0.072 | Dopamine beta hydroxylase inhibitor | 0.061 0.014 CID_50591 0.072 0.007 CID_524508 | CID_524508 | |
| 0.088 | 0.035 | 0.088 | Syk tyrosine kinase inhibitor | 0.068 0.051 CID_321710 0.068 0.051 CID_524508 | ||
| 0.092 | 0.04 | 0.092 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.08 0.053 CID_524508 | ||
| 0.074 | 0.023 | 0.074 | Histone deacetylase SIRT3 inhibitor | 0.072 0.025 CID_321710 0.058 0.057 CID_50591 0.063 0.041 CID_524508 | ||
| 0.072 | 0.021 | 0.072 | mTOR inhibitor | 0.059 0.03 CID_524508 | ||
| 0.127 | 0.076 | 0.127 | Nav1.2 sodium channel blocker | 0.106 0.102 CID_321710 | ||
| 0.097 | 0.047 | 0.097 | Glutamate release inhibitor | 0.089 0.064 CID_321710 0.093 0.055 CID_50591 0.09 0.061 CID_524508 | ||
| 0.136 | 0.086 | 0.165 | Hemostatic | 0.165 0.052 CID_321710 0.131 0.094 CID_524508 | CID_321710 | |
| 0.073 | 0.023 | 0.087 | Beta 1 adrenoreceptor antagonist | 0.077 0.02 CID_321710 0.071 0.025 CID_50591 0.087 0.014 CID_524508 | CID_524508 | |
| 0.121 | 0.071 | 0.122 | Sphingosine 1-phosphate receptor 4 antagonist | 0.122 0.068 CID_321710 0.107 0.101 CID_524508 | CID_321710 | |
| 0.082 | 0.032 | 0.134 | Acetylcholine M5 receptor agonist | 0.134 0.007 CID_321710 | CID_321710 | |
| 0.071 | 0.021 | 0.118 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.079 0.017 CID_50591 0.118 0.008 CID_524508 | CID_524508 | |
| 0.053 | 0.004 | 0.053 | Imidazoline I1 receptor antagonist | 0.026 0.009 CID_321710 0.019 0.016 CID_50591 0.025 0.01 CID_524508 | ||
| 0.077 | 0.027 | 0.077 | Carbonic anhydrase stimulant | 0.064 0.037 CID_50591 0.057 0.044 CID_524508 | ||
| 0.058 | 0.009 | 0.081 | 5 Hydroxytryptamine 2B agonist | 0.081 0.005 CID_321710 0.036 0.033 CID_50591 0.038 0.028 CID_524508 | CID_321710 | |
| 0.089 | 0.041 | 0.089 | Fibroblast growth factor 3 antagonist | |||
| 0.064 | 0.015 | 0.076 | Adenylate cyclase 1 inhibitor | 0.076 0.009 CID_321710 0.06 0.017 CID_50591 0.051 0.025 CID_524508 | CID_321710 | |
| 0.151 | 0.103 | 0.175 | Phospholipase C inhibitor | 0.15 0.106 CID_321710 0.175 0.067 CID_50591 0.165 0.08 CID_524508 | CID_50591 | |
| 0.066 | 0.019 | 0.067 | Pregnane X receptor antagonist | 0.061 0.028 CID_321710 0.067 0.018 CID_50591 0.066 0.02 CID_524508 | CID_50591 | |
| 0.063 | 0.016 | 0.063 | Cholecystokinin A antagonist | |||
| 0.089 | 0.042 | 0.147 | Alpha 2a adrenoreceptor antagonist | 0.147 0.023 CID_321710 0.082 0.047 CID_524508 | CID_321710 | |
| 0.061 | 0.014 | 0.086 | Progesterone antagonist | 0.086 0.01 CID_321710 0.037 0.024 CID_524508 | CID_321710 | |
| 0.104 | 0.057 | 0.192 | Xanthine oxidase inhibitor | 0.158 0.031 CID_50591 0.192 0.021 CID_524508 | CID_524508 | |
| 0.159 | 0.113 | 0.235 | Antimitotic | 0.235 0.066 CID_524508 | CID_524508 | |
| 0.067 | 0.021 | 0.078 | Ryanodine receptor antagonist | 0.063 0.029 CID_321710 0.066 0.024 CID_50591 0.078 0.01 CID_524508 | CID_524508 | |
| 0.112 | 0.066 | 0.135 | Nav1.5 sodium channel blocker | 0.135 0.038 CID_321710 | CID_321710 | |
| 0.059 | 0.014 | 0.059 | Benzodiazepine antagonist | 0.054 0.021 CID_321710 | ||
| 0.074 | 0.028 | 0.135 | Xanthine dehydrogenase inhibitor | 0.064 0.035 CID_50591 0.135 0.009 CID_524508 | CID_524508 | |
| 0.063 | 0.017 | 0.063 | Cholecystokinin antagonist | 0.038 0.031 CID_321710 | ||
| 0.063 | 0.018 | 0.063 | Aldosterone antagonist | 0.056 0.023 CID_321710 | ||
| 0.082 | 0.037 | 0.082 | CDK2/cyclin E2 inhibitor | |||
| 0.084 | 0.039 | 0.084 | Aminopeptidase I inhibitor | 0.074 0.048 CID_321710 0.075 0.048 CID_50591 0.079 0.043 CID_524508 | ||
| 0.093 | 0.048 | 0.093 | Bcr-Abl kinase inhibitor | 0.09 0.052 CID_524508 | ||
| 0.086 | 0.042 | 0.145 | Alpha 1b adrenoreceptor antagonist | 0.145 0.023 CID_321710 0.069 0.054 CID_524508 | CID_321710 | |
| 0.109 | 0.065 | 0.109 | DNA intercalator | 0.106 0.068 CID_524508 | ||
| 0.083 | 0.04 | 0.083 | Adenosine A3 receptor antagonist | 0.069 0.059 CID_524508 | ||
| 0.065 | 0.023 | 0.156 | AMPA receptor antagonist | 0.156 0.005 CID_321710 0.047 0.034 CID_50591 0.049 0.032 CID_524508 | CID_321710 | |
| 0.094 | 0.052 | 0.094 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.087 0.061 CID_321710 | ||
| 0.075 | 0.032 | 0.128 | NMDA receptor glycine site agonist | 0.128 0.007 CID_321710 0.088 0.023 CID_50591 | CID_321710 | |
| 0.121 | 0.078 | 0.126 | RET inhibitor | 0.126 0.074 CID_524508 | CID_524508 | |
| 0.06 | 0.018 | 0.06 | Glutamate (mGluR group III) agonist | 0.053 0.022 CID_321710 0.046 0.027 CID_524508 | ||
| 0.048 | 0.006 | 0.048 | Nicotinic alpha3beta4 receptor agonist | 0.046 0.007 CID_321710 0.032 0.017 CID_50591 0.04 0.01 CID_524508 | ||
| 0.071 | 0.029 | 0.073 | Transcription factor RelA inhibitor | 0.063 0.046 CID_50591 0.073 0.025 CID_524508 | CID_524508 | |
| 0.055 | 0.014 | 0.094 | Dopamine D5 agonist | 0.055 0.014 CID_321710 0.084 0.005 CID_50591 0.094 0.005 CID_524508 | CID_524508 | |
| 0.152 | 0.111 | 0.258 | Anesthetic general | 0.258 0.047 CID_321710 0.166 0.098 CID_50591 0.144 0.12 CID_524508 | CID_321710 | |
| 0.074 | 0.033 | 0.099 | Beta adrenoreceptor antagonist | 0.081 0.026 CID_321710 0.096 0.018 CID_50591 0.099 0.017 CID_524508 | CID_524508 | |
| 0.124 | 0.083 | 0.124 | Tyrosine-protein kinase receptor antagonist | |||
| 0.064 | 0.023 | 0.08 | Dihydroorotate oxidase inhibitor | 0.08 0.011 CID_321710 0.062 0.027 CID_50591 0.07 0.017 CID_524508 | CID_321710 | |
| 0.087 | 0.046 | 0.108 | Caspase 7 inhibitor | 0.108 0.021 CID_321710 0.077 0.068 CID_50591 | CID_321710 | |
| 0.073 | 0.032 | 0.098 | Aromatase inhibitor | 0.052 0.047 CID_321710 0.098 0.022 CID_524508 | CID_524508 | |
| 0.089 | 0.049 | 0.089 | ALK inhibitor | |||
| 0.066 | 0.026 | 0.319 | Cyclin B2 inhibitor | 0.319 0.004 CID_321710 0.062 0.03 CID_50591 0.066 0.025 CID_524508 | CID_321710 | |
| 0.075 | 0.035 | 0.075 | Histone deacetylase inhibitor | 0.069 0.042 CID_321710 | ||
| 0.045 | 0.005 | 0.045 | 5 Hydroxytryptamine 6 agonist | 0.027 0.024 CID_321710 0.032 0.015 CID_50591 | ||
| 0.196 | 0.156 | 0.25 | Hypoxia-inducible factor 1 alpha inhibitor | 0.21 0.141 CID_321710 0.21 0.14 CID_50591 0.25 0.1 CID_524508 | CID_524508 | |
| 0.091 | 0.052 | 0.135 | 5 Hydroxytryptamine 2A antagonist | 0.135 0.032 CID_321710 | CID_321710 | |
| 0.093 | 0.054 | 0.105 | Aminoacyl-tRNA synthetase inhibitor | 0.105 0.04 CID_50591 0.093 0.054 CID_524508 | CID_50591 | |
| 0.093 | 0.053 | 0.118 | Alpha 2 adrenoreceptor antagonist | 0.118 0.037 CID_321710 0.08 0.066 CID_524508 | CID_321710 | |
| 0.074 | 0.035 | 0.074 | Exportin-1 inhibitor | 0.071 0.04 CID_321710 | ||
| 0.117 | 0.078 | 0.389 | Glutamate receptor antagonist | 0.389 0.005 CID_321710 0.107 0.088 CID_524508 | CID_321710 | |
| 0.132 | 0.093 | 0.132 | Thiol protease inhibitor | |||
| 0.113 | 0.075 | 0.151 | Alkylator | 0.096 0.093 CID_321710 0.097 0.092 CID_50591 0.151 0.046 CID_524508 | CID_524508 | |
| 0.084 | 0.046 | 0.084 | MAP kinase 10 inhibitor | |||
| 0.138 | 0.1 | 0.203 | Heat shock protein 90 alpha antagonist | 0.149 0.087 CID_50591 0.203 0.048 CID_524508 | CID_524508 | |
| 0.063 | 0.025 | 0.063 | Histamine agonist | 0.054 0.034 CID_321710 | ||
| 0.045 | 0.009 | 0.048 | Protein kinase (CK2) beta inhibitor | 0.032 0.025 CID_321710 0.036 0.017 CID_50591 0.048 0.008 CID_524508 | CID_524508 | |
| 0.068 | 0.032 | 0.068 | Calcium channel P-type blocker | 0.063 0.045 CID_321710 | ||
| 0.08 | 0.044 | 0.266 | NMDA 2 receptor antagonist | 0.266 0.005 CID_321710 0.104 0.03 CID_50591 0.143 0.018 CID_524508 | CID_321710 | |
| 0.105 | 0.069 | 0.105 | Vascular endothelial growth factor 2 antagonist | |||
| 0.049 | 0.013 | 0.049 | MAP3K5 inhibitor | |||
| 0.06 | 0.025 | 0.06 | H+/K+-transporting ATPase inhibitor | 0.047 0.041 CID_524508 | ||
| 0.071 | 0.035 | 0.128 | NMDA receptor agonist | 0.128 0.012 CID_321710 0.077 0.03 CID_50591 0.059 0.049 CID_524508 | CID_321710 | |
| 0.09 | 0.055 | 0.09 | Stem cell growth factor agonist | |||
| 0.049 | 0.014 | 0.049 | Bombesin 1 receptor antagonist | 0.036 0.026 CID_50591 | ||
| 0.053 | 0.018 | 0.081 | Glutamate (mGluR group III) antagonist | 0.081 0.007 CID_321710 0.044 0.029 CID_524508 | CID_321710 | |
| 0.058 | 0.023 | 0.058 | Potassium channel (Inward rectifier) activator | 0.051 0.034 CID_321710 | ||
| 0.04 | 0.005 | 0.055 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.037 0.005 CID_50591 0.055 0.004 CID_524508 | CID_524508 | |
| 0.076 | 0.041 | 0.423 | Cyclin B3 inhibitor | 0.423 0.003 CID_321710 0.082 0.037 CID_50591 0.084 0.036 CID_524508 | CID_321710 | |
| 0.069 | 0.035 | 0.08 | Carbamoyl phosphate synthetase inhibitor | 0.08 0.029 CID_321710 0.073 0.032 CID_50591 0.065 0.039 CID_524508 | CID_321710 | |
| 0.038 | 0.004 | 0.038 | Alpha 2b adrenoreceptor agonist | 0.024 0.006 CID_524508 | ||
| 0.039 | 0.004 | 0.039 | Alpha 2a adrenoreceptor agonist | 0.021 0.008 CID_50591 0.022 0.008 CID_524508 | ||
| 0.081 | 0.047 | 0.127 | Keratolytic | 0.072 0.061 CID_321710 0.101 0.03 CID_50591 0.127 0.019 CID_524508 | CID_524508 | |
| 0.068 | 0.034 | 0.29 | Cyclin B1 inhibitor | 0.29 0.004 CID_321710 0.059 0.045 CID_50591 0.068 0.034 CID_524508 | CID_321710 | |
| 0.102 | 0.068 | 0.148 | Mediator release inhibitor | 0.148 0.03 CID_321710 0.115 0.052 CID_50591 0.126 0.043 CID_524508 | CID_321710 | |
| 0.041 | 0.007 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.013 CID_321710 0.033 0.014 CID_524508 | ||
| 0.056 | 0.023 | 0.056 | Mineralocorticoid receptor antagonist | |||
| 0.055 | 0.022 | 0.055 | Potassium channel (ATP-sensitive) activator | 0.048 0.033 CID_321710 | ||
| 0.135 | 0.102 | 0.174 | Interferon gamma antagonist | 0.145 0.085 CID_321710 0.152 0.075 CID_50591 0.174 0.054 CID_524508 | CID_524508 | |
| 0.125 | 0.093 | 0.171 | Cell wall synthesis inhibitor | 0.126 0.091 CID_321710 0.171 0.046 CID_50591 0.134 0.081 CID_524508 | CID_50591 | |
| 0.039 | 0.007 | 0.039 | Thymidine phosphorylase inhibitor | 0.026 0.017 CID_321710 0.026 0.018 CID_50591 0.033 0.01 CID_524508 | ||
| 0.093 | 0.061 | 0.115 | Potassium channel (Ca-activated) activator | 0.086 0.069 CID_321710 0.108 0.049 CID_50591 0.115 0.044 CID_524508 | CID_524508 | |
| 0.044 | 0.013 | 0.044 | Glutamate (mGluR4) agonist | 0.038 0.018 CID_524508 | ||
| 0.129 | 0.098 | 0.208 | Heat shock protein 90 antagonist | 0.135 0.091 CID_50591 0.208 0.034 CID_524508 | CID_524508 | |
| 0.063 | 0.032 | 0.063 | Cyclin A1 inhibitor | |||
| 0.048 | 0.017 | 0.116 | Kainate receptor 2 antagonist | 0.116 0.004 CID_321710 | CID_321710 | |
| 0.051 | 0.02 | 0.084 | Glutamate (mGluR4) antagonist | 0.084 0.008 CID_321710 0.04 0.038 CID_50591 0.04 0.038 CID_524508 | CID_321710 | |
| 0.042 | 0.011 | 0.042 | Transforming growth factor beta 2 antagonist | |||
| 0.048 | 0.017 | 0.119 | AMPA 4 receptor antagonist | 0.119 0.004 CID_321710 0.039 0.029 CID_50591 0.041 0.024 CID_524508 | CID_321710 | |
| 0.066 | 0.036 | 0.084 | Purinergic P2X1 antagonist | 0.055 0.053 CID_321710 0.084 0.023 CID_50591 0.071 0.031 CID_524508 | CID_50591 | |
| 0.063 | 0.033 | 0.063 | Botulinum neurotoxin type A inhibitor | 0.061 0.035 CID_50591 0.063 0.034 CID_524508 | ||
| 0.039 | 0.01 | 0.039 | Protein kinase C beta I inhibitor | 0.035 0.019 CID_321710 0.038 0.012 CID_50591 0.037 0.014 CID_524508 | ||
| 0.046 | 0.016 | 0.046 | 5 Hydroxytryptamine 3B antagonist | 0.037 0.024 CID_321710 | ||
| 0.034 | 0.004 | 0.034 | Alpha 2c adrenoreceptor agonist | 0.018 0.015 CID_524508 | ||
| 0.051 | 0.021 | 0.056 | Histone deacetylase 8 inhibitor | 0.056 0.018 CID_321710 | CID_321710 | |
| 0.051 | 0.021 | 0.051 | AICAR transformylase inhibitor | 0.049 0.023 CID_524508 | ||
| 0.04 | 0.011 | 0.04 | Epoxide hydrolase 1 inhibitor | |||
| 0.044 | 0.015 | 0.044 | Somatostatin agonist | 0.028 0.026 CID_50591 0.03 0.023 CID_524508 | ||
| 0.067 | 0.039 | 0.071 | Interferon inducer | 0.071 0.033 CID_50591 | CID_50591 | |
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | 0.03 0.018 CID_321710 0.032 0.016 CID_50591 0.035 0.014 CID_524508 | ||
| 0.08 | 0.051 | 0.17 | Macrophage migration inhibitory factor inhibitor | 0.108 0.03 CID_321710 0.096 0.037 CID_50591 0.17 0.011 CID_524508 | CID_524508 | |
| 0.063 | 0.035 | 0.077 | Phosphodiesterase 1A inhibitor | 0.077 0.018 CID_321710 | CID_321710 | |
| 0.079 | 0.051 | 0.145 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.14 0.022 CID_50591 0.145 0.02 CID_524508 | CID_524508 | |
| 0.079 | 0.051 | 0.083 | Focal adhesion kinase 1 inhibitor | 0.083 0.046 CID_321710 | CID_321710 | |
| 0.062 | 0.034 | 0.062 | 5 Hydroxytryptamine 3 antagonist | 0.051 0.047 CID_321710 | ||
| 0.054 | 0.026 | 0.054 | Histamine H4 receptor antagonist | 0.044 0.043 CID_321710 | ||
| 0.076 | 0.049 | 0.086 | Glutamate dehydrogenase inhibitor | 0.079 0.046 CID_321710 0.086 0.039 CID_50591 0.075 0.05 CID_524508 | CID_50591 | |
| 0.051 | 0.024 | 0.159 | Phosphodiesterase 3B inhibitor | 0.159 0.005 CID_321710 0.064 0.018 CID_524508 | CID_321710 | |
| 0.073 | 0.045 | 0.073 | Secretase beta inhibitor | |||
| 0.076 | 0.048 | 0.126 | Glutamate decarboxylase inhibitor | 0.08 0.044 CID_321710 0.117 0.022 CID_50591 0.126 0.019 CID_524508 | CID_524508 | |
| 0.059 | 0.032 | 0.059 | MAP kinase kinase 9 inhibitor | |||
| 0.08 | 0.053 | 0.084 | Interferon agonist | 0.084 0.046 CID_50591 | CID_50591 | |
| 0.063 | 0.036 | 0.104 | Heat shock protein 90 beta antagonist | 0.073 0.026 CID_50591 0.104 0.01 CID_524508 | CID_524508 | |
| 0.06 | 0.033 | 0.06 | Bombesin 3 receptor antagonist | |||
| 0.07 | 0.044 | 0.07 | Nav1.7 sodium channel blocker | |||
| 0.076 | 0.049 | 0.076 | Phosphodiesterase VI inhibitor | 0.072 0.056 CID_321710 0.071 0.059 CID_50591 0.076 0.048 CID_524508 | ||
| 0.044 | 0.018 | 0.044 | Somatostatin 4 agonist | 0.038 0.024 CID_524508 | ||
| 0.048 | 0.021 | 0.048 | Somatostatin 1 antagonist | 0.036 0.029 CID_50591 0.042 0.024 CID_524508 | ||
| 0.054 | 0.028 | 0.054 | Bombesin 2 receptor antagonist | 0.051 0.032 CID_50591 0.047 0.039 CID_524508 | ||
| 0.069 | 0.044 | 0.161 | Phosphodiesterase III inhibitor | 0.161 0.009 CID_321710 0.065 0.048 CID_524508 | CID_321710 | |
| 0.056 | 0.031 | 0.056 | Heparanase inhibitor | 0.053 0.036 CID_524508 | ||
| 0.059 | 0.033 | 0.276 | Cyclin B inhibitor | 0.276 0.004 CID_321710 0.054 0.039 CID_50591 0.058 0.034 CID_524508 | CID_321710 | |
| 0.105 | 0.08 | 0.138 | Adenylate cyclase inhibitor | 0.138 0.053 CID_321710 0.123 0.065 CID_50591 0.113 0.073 CID_524508 | CID_321710 | |
| 0.083 | 0.058 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.042 | 0.017 | 0.042 | Somatostatin 5 agonist | |||
| 0.055 | 0.03 | 0.073 | Beta 2 adrenoreceptor antagonist | 0.063 0.022 CID_321710 0.058 0.026 CID_50591 0.073 0.015 CID_524508 | CID_524508 | |
| 0.164 | 0.14 | 0.178 | Tumour necrosis factor alpha release inhibitor | 0.178 0.128 CID_524508 | CID_524508 | |
| 0.054 | 0.029 | 0.054 | Adenosine A2b receptor antagonist | |||
| 0.047 | 0.023 | 0.047 | Nerve growth factor antagonist | 0.047 0.023 CID_321710 0.041 0.033 CID_50591 | ||
| 0.05 | 0.027 | 0.296 | Dopamine D2 agonist | 0.296 0.004 CID_321710 0.093 0.012 CID_524508 | CID_321710 | |
| 0.068 | 0.044 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.035 CID_321710 0.066 0.048 CID_50591 | CID_321710 | |
| 0.037 | 0.013 | 0.037 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.097 | 0.074 | 0.097 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.092 | 0.069 | 0.103 | Bile acid receptor antagonist | 0.101 0.046 CID_321710 0.09 0.074 CID_50591 0.103 0.044 CID_524508 | CID_524508 | |
| 0.07 | 0.047 | 0.089 | Phosphofructokinase-1 inhibitor | 0.069 0.048 CID_321710 0.089 0.036 CID_50591 0.081 0.041 CID_524508 | CID_50591 | |
| 0.037 | 0.014 | 0.037 | Protein kinase C beta II inhibitor | 0.036 0.016 CID_321710 0.033 0.022 CID_50591 0.034 0.019 CID_524508 | ||
| 0.082 | 0.059 | 0.095 | Inducible nitric-oxide synthase inhibitor | 0.095 0.042 CID_321710 | CID_321710 | |
| 0.055 | 0.033 | 0.151 | NMDA 2A receptor antagonist | 0.151 0.007 CID_321710 0.083 0.018 CID_50591 0.072 0.023 CID_524508 | CID_321710 | |
| 0.074 | 0.052 | 0.077 | Vanilloid 4 agonist | 0.077 0.046 CID_321710 | CID_321710 | |
| 0.051 | 0.029 | 0.052 | Adenosine deaminase inhibitor | 0.052 0.028 CID_524508 | CID_524508 | |
| 0.087 | 0.065 | 0.087 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.078 0.074 CID_524508 | ||
| 0.158 | 0.136 | 0.215 | Antiamyloidogenic | 0.207 0.095 CID_50591 0.215 0.09 CID_524508 | CID_524508 | |
| 0.026 | 0.005 | 0.026 | Somatostatin 3 agonist | 0.021 0.009 CID_524508 | ||
| 0.03 | 0.009 | 0.03 | Alpha 2d adrenoreceptor agonist | |||
| 0.024 | 0.004 | 0.024 | Imidazoline I2 receptor antagonist | 0.01 0.009 CID_524508 | ||
| 0.035 | 0.014 | 0.035 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 CID_321710 | ||
| 0.056 | 0.036 | 0.058 | Epithelial sodium channel blocker | 0.058 0.033 CID_524508 | CID_524508 | |
| 0.036 | 0.016 | 0.036 | GHS receptor antagonist | |||
| 0.068 | 0.048 | 0.068 | Toll-Like receptor 7 antagonist | |||
| 0.089 | 0.069 | 0.133 | Platelet activating factor alpha antagonist | 0.133 0.037 CID_524508 | CID_524508 | |
| 0.057 | 0.038 | 0.063 | Carbonic anhydrase VB inhibitor | 0.052 0.042 CID_50591 0.063 0.033 CID_524508 | CID_524508 | |
| 0.062 | 0.043 | 0.062 | Phosphodiesterase 1C inhibitor | 0.061 0.047 CID_321710 | ||
| 0.09 | 0.071 | 0.137 | Interleukin 12 antagonist | 0.102 0.05 CID_321710 0.092 0.069 CID_50591 0.137 0.017 CID_524508 | CID_524508 | |
| 0.044 | 0.025 | 0.044 | DNA-dependent protein kinase inhibitor | 0.042 0.027 CID_524508 | ||
| 0.074 | 0.056 | 0.09 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 CID_50591 0.09 0.041 CID_524508 | CID_524508 | |
| 0.025 | 0.007 | 0.026 | Cyclin T1 inhibitor | 0.026 0.006 CID_321710 | CID_321710 | |
| 0.186 | 0.167 | 0.265 | 12-Lipoxygenase inhibitor | 0.254 0.107 CID_50591 0.265 0.1 CID_524508 | CID_524508 | |
| 0.043 | 0.024 | 0.043 | Dopamine D3 agonist | 0.043 0.024 CID_321710 0.041 0.026 CID_524508 | ||
| 0.038 | 0.02 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.038 0.02 CID_321710 | ||
| 0.046 | 0.029 | 0.047 | Fructose-1,6-bisphosphatase inhibitor | 0.047 0.028 CID_524508 | CID_524508 | |
| 0.03 | 0.014 | 0.048 | Methionyl aminopeptidase 2 inhibitor | 0.048 0.007 CID_321710 | CID_321710 | |
| 0.034 | 0.018 | 0.034 | Endothelial nitric-oxide synthase inhibitor | 0.03 0.023 CID_321710 | ||
| 0.142 | 0.126 | 0.184 | Catenin beta inhibitor | 0.184 0.047 CID_524508 | CID_524508 | |
| 0.082 | 0.066 | 0.115 | CDK/cyclin complex inhibitor | 0.115 0.043 CID_321710 | CID_321710 | |
| 0.163 | 0.147 | 0.275 | ErbB-1 antagonist | 0.275 0.041 CID_321710 0.16 0.155 CID_50591 0.248 0.052 CID_524508 | CID_321710 | |
| 0.149 | 0.134 | 0.173 | Insulin sensitizer | 0.173 0.103 CID_524508 | CID_524508 | |
| 0.054 | 0.038 | 0.054 | Lysine-specific demethylase 1A inhibitor | |||
| 0.101 | 0.086 | 0.101 | Proteasome inhibitor | |||
| 0.201 | 0.186 | 0.208 | Calpain 2 inhibitor | 0.208 0.18 CID_321710 | CID_321710 | |
| 0.048 | 0.033 | 0.048 | Bombesin antagonist | |||
| 0.051 | 0.036 | 0.051 | 5 Hydroxytryptamine 4 antagonist | 0.05 0.037 CID_321710 | ||
| 0.042 | 0.027 | 0.052 | Kainate receptor agonist | 0.052 0.012 CID_321710 0.043 0.025 CID_50591 0.04 0.032 CID_524508 | CID_321710 | |
| 0.028 | 0.013 | 0.031 | Acid ceramidase inhibitor | 0.031 0.008 CID_321710 | CID_321710 | |
| 0.057 | 0.043 | 0.094 | Alpha 1d adrenoreceptor antagonist | 0.094 0.025 CID_321710 | CID_321710 | |
| 0.04 | 0.026 | 0.04 | Histone deacetylase class I inhibitor | 0.036 0.031 CID_321710 | ||
| 0.076 | 0.063 | 0.136 | Adrenaline agonist | 0.107 0.033 CID_321710 0.083 0.053 CID_50591 0.136 0.019 CID_524508 | CID_524508 | |
| 0.07 | 0.056 | 0.07 | Orexin receptor 1 antagonist | |||
| 0.07 | 0.056 | 0.07 | Vanilloid antagonist | |||
| 0.021 | 0.007 | 0.021 | Granulocyte colony stimulating factor receptor agonist | 0.018 0.013 CID_50591 | ||
| 0.072 | 0.058 | 0.072 | Potassium channel (Tandem pore domain) blocker | |||
| 0.108 | 0.095 | 0.108 | Lck kinase inhibitor | |||
| 0.035 | 0.022 | 0.035 | Free fatty acid receptor 1 antagonist | |||
| 0.039 | 0.026 | 0.039 | TRPM8 blocker | |||
| 0.024 | 0.011 | 0.024 | Somatostatin 3 antagonist | |||
| 0.04 | 0.027 | 0.043 | CF transmembrane conductance regulator antagonist | 0.043 0.018 CID_50591 0.043 0.018 CID_524508 | CID_524508 | |
| 0.025 | 0.012 | 0.025 | ICAM 1 antagonist | 0.022 0.018 CID_524508 | ||
| 0.024 | 0.011 | 0.024 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.08 | 0.067 | 0.103 | Estrogen-related receptor beta agonist | 0.084 0.055 CID_321710 0.095 0.031 CID_50591 0.103 0.021 CID_524508 | CID_524508 | |
| 0.079 | 0.066 | 0.149 | Antineoplastic alkaloid | 0.085 0.06 CID_50591 0.149 0.028 CID_524508 | CID_524508 | |
| 0.06 | 0.047 | 0.06 | Cyclin A2 inhibitor | 0.055 0.052 CID_321710 | ||
| 0.047 | 0.034 | 0.05 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.035 CID_321710 0.05 0.029 CID_50591 0.046 0.036 CID_524508 | CID_50591 | |
| 0.029 | 0.016 | 0.029 | Myristoyl transferase inhibitor | |||
| 0.027 | 0.014 | 0.027 | Complement factor 1s inhibitor | |||
| 0.018 | 0.005 | 0.018 | CC chemokine 10 receptor antagonist | |||
| 0.03 | 0.018 | 0.03 | MAP3K8 inhibitor | |||
| 0.041 | 0.029 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.053 0.012 CID_50591 0.05 0.015 CID_524508 | CID_50591 | |
| 0.053 | 0.041 | 0.053 | CC chemokine 2 receptor antagonist | |||
| 0.077 | 0.065 | 0.077 | Phosphodiesterase XI inhibitor | |||
| 0.077 | 0.065 | 0.077 | Phosphodiesterase 11A inhibitor | |||
| 0.055 | 0.043 | 0.055 | CDK4/cyclin D1 inhibitor | |||
| 0.032 | 0.021 | 0.032 | Potassium channel small-conductance Ca-activated activator | |||
| 0.058 | 0.047 | 0.07 | Dopamine D3 antagonist | 0.07 0.037 CID_321710 | CID_321710 | |
| 0.039 | 0.027 | 0.066 | Vascular adhesion protein 1 inhibitor | 0.066 0.007 CID_321710 | CID_321710 | |
| 0.069 | 0.057 | 0.099 | Glycine receptor agonist | 0.099 0.021 CID_321710 0.081 0.037 CID_50591 | CID_321710 | |
| 0.045 | 0.034 | 0.055 | Thymidylate synthase inhibitor | 0.055 0.022 CID_321710 0.042 0.039 CID_50591 | CID_321710 | |
| 0.044 | 0.033 | 0.044 | Oleamide hydrolase inhibitor | |||
| 0.057 | 0.046 | 0.111 | Androgen agonist | 0.111 0.011 CID_321710 0.065 0.035 CID_50591 0.068 0.032 CID_524508 | CID_321710 | |
| 0.019 | 0.008 | 0.019 | Nicotinic alpha4 receptor agonist | |||
| 0.053 | 0.042 | 0.053 | Glucosylceramidase inhibitor | 0.05 0.048 CID_50591 | ||
| 0.021 | 0.01 | 0.021 | Follicle-stimulating hormone antagonist | |||
| 0.116 | 0.106 | 0.122 | Sphingosine 1-phosphate receptor 2 antagonist | 0.114 0.111 CID_321710 0.121 0.095 CID_50591 0.122 0.091 CID_524508 | CID_524508 | |
| 0.037 | 0.027 | 0.037 | Melanocortin 1 antagonist | 0.034 0.031 CID_321710 | ||
| 0.092 | 0.081 | 0.092 | Hedgehog signaling inhibitor | |||
| 0.044 | 0.034 | 0.07 | Phosphorylase inhibitor | 0.07 0.02 CID_321710 | CID_321710 | |
| 0.027 | 0.017 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.031 0.01 CID_321710 0.026 0.02 CID_50591 | CID_321710 | |
| 0.027 | 0.017 | 0.044 | Thyroid hormone agonist | 0.037 0.007 CID_50591 0.044 0.005 CID_524508 | CID_524508 | |
| 0.022 | 0.012 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.029 0.005 CID_321710 0.021 0.014 CID_50591 | CID_321710 | |
| 0.017 | 0.008 | 0.017 | CXC chemokine 4 receptor agonist | 0.016 0.009 CID_321710 | ||
| 0.089 | 0.08 | 0.109 | Anabolic | 0.106 0.055 CID_321710 0.102 0.06 CID_50591 0.109 0.051 CID_524508 | CID_524508 | |
| 0.032 | 0.023 | 0.032 | Glucocorticoid antagonist | |||
| 0.039 | 0.031 | 0.047 | Thymidine kinase inhibitor | 0.047 0.021 CID_321710 0.038 0.035 CID_50591 | CID_321710 | |
| 0.043 | 0.034 | 0.046 | Dihydroorotase inhibitor | 0.046 0.03 CID_321710 | CID_321710 | |
| 0.189 | 0.18 | 0.286 | Transcription factor NF kappa B inhibitor | 0.24 0.135 CID_321710 0.22 0.15 CID_50591 0.286 0.102 CID_524508 | CID_524508 | |
| 0.194 | 0.185 | 0.233 | Antithrombotic | 0.233 0.14 CID_321710 | CID_321710 | |
| 0.027 | 0.019 | 0.027 | Glucosylceramidase stimulant | |||
| 0.017 | 0.009 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 CID_321710 | CID_321710 | |
| 0.023 | 0.015 | 0.023 | Glutamate (mGluR1a) agonist | 0.02 0.019 CID_321710 | ||
| 0.043 | 0.035 | 0.08 | Poly(ADP-ribose) polymerase inhibitor | 0.08 0.01 CID_321710 | CID_321710 | |
| 0.03 | 0.022 | 0.035 | Lysophosphatidic acid 2 receptor antagonist | 0.035 0.016 CID_321710 | CID_321710 | |
| 0.042 | 0.034 | 0.042 | Heme oxygenase inhibitor | |||
| 0.056 | 0.049 | 0.075 | 5 Hydroxytryptamine 7 antagonist | 0.075 0.034 CID_321710 | CID_321710 | |
| 0.086 | 0.079 | 0.093 | Interleukin 1 beta converting enzyme inhibitor | 0.093 0.067 CID_321710 | CID_321710 | |
| 0.064 | 0.058 | 0.064 | Amidase inhibitor | 0.062 0.061 CID_524508 | ||
| 0.05 | 0.043 | 0.058 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.035 CID_321710 | CID_321710 | |
| 0.056 | 0.05 | 0.056 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.037 | 0.031 | 0.04 | Vanilloid 3 antagonist | 0.04 0.023 CID_321710 | CID_321710 | |
| 0.055 | 0.049 | 0.055 | Cyclin A inhibitor | |||
| 0.176 | 0.17 | 0.179 | Transcription factor STAT3 inhibitor | 0.179 0.165 CID_524508 | CID_524508 | |
| 0.059 | 0.053 | 0.059 | Fibroblast growth factor 2 antagonist | |||
| 0.08 | 0.075 | 0.117 | MAO B inhibitor | 0.089 0.067 CID_321710 0.117 0.052 CID_524508 | CID_524508 | |
| 0.028 | 0.023 | 0.028 | Cholecystokinin B antagonist | |||
| 0.026 | 0.02 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 CID_321710 | CID_321710 | |
| 0.035 | 0.03 | 0.048 | Cholecystokinin B agonist | 0.048 0.017 CID_321710 0.034 0.032 CID_524508 | CID_321710 | |
| 0.013 | 0.009 | 0.014 | Cyclin D2 inhibitor | 0.014 0.008 CID_321710 | CID_321710 | |
| 0.04 | 0.035 | 0.147 | NMDA receptor subunit 3B antagonist | 0.147 0.006 CID_321710 0.082 0.013 CID_50591 0.077 0.014 CID_524508 | CID_321710 | |
| 0.013 | 0.008 | 0.013 | Integrin beta2 antagonist | |||
| 0.066 | 0.062 | 0.109 | Acetylcholine M4 receptor antagonist | 0.109 0.022 CID_321710 | CID_321710 | |
| 0.038 | 0.034 | 0.039 | Growth hormone release inhibitor | 0.039 0.033 CID_321710 0.037 0.035 CID_50591 | CID_321710 | |
| 0.026 | 0.022 | 0.026 | Hedgehog signaling activator | |||
| 0.109 | 0.105 | 0.164 | Protein kinase stimulant | 0.114 0.099 CID_321710 0.152 0.067 CID_50591 0.164 0.059 CID_524508 | CID_524508 | |
| 0.04 | 0.036 | 0.04 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.034 | 0.031 | 0.048 | Glutamate (mGluR3) antagonist | 0.048 0.014 CID_321710 | CID_321710 | |
| 0.017 | 0.014 | 0.017 | Histamine H4 receptor agonist | |||
| 0.055 | 0.052 | 0.058 | Gonadotropin-releasing hormone receptor agonist | 0.058 0.044 CID_524508 | CID_524508 | |
| 0.051 | 0.048 | 0.051 | Dopamine uptake inhibitor | |||
| 0.026 | 0.024 | 0.07 | AMPA 3 receptor antagonist | 0.07 0.005 CID_321710 | CID_321710 | |
| 0.017 | 0.015 | 0.017 | Complement factor D inhibitor | |||
| 0.061 | 0.059 | 0.069 | Carbonic anhydrase VA inhibitor | 0.069 0.047 CID_524508 | CID_524508 | |
| 0.009 | 0.007 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 CID_50591 | ||
| 0.036 | 0.033 | 0.1 | Kainate receptor antagonist | 0.1 0.007 CID_321710 | CID_321710 | |
| 0.021 | 0.019 | 0.021 | Bombesin agonist | |||
| 0.026 | 0.024 | 0.033 | Glucagon receptor antagonist | 0.033 0.018 CID_524508 | CID_524508 | |
| 0.027 | 0.025 | 0.027 | Somatostatin 5 antagonist | |||
| 0.025 | 0.023 | 0.104 | AMPA 1 receptor antagonist | 0.104 0.005 CID_321710 | CID_321710 | |
| 0.029 | 0.027 | 0.039 | Sirtuin 2 inhibitor | 0.039 0.018 CID_321710 | CID_321710 | |
| 0.011 | 0.01 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 CID_321710 | CID_321710 | |
| 0.006 | 0.005 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.034 | 0.032 | 0.034 | Integrin alpha2 antagonist | |||
| 0.078 | 0.077 | 0.078 | Fibroblast growth factor 1 antagonist | |||
| 0.011 | 0.01 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.009 CID_50591 | ||
| 0.019 | 0.018 | 0.019 | Adenosine kinase inhibitor | |||
| 0.035 | 0.034 | 0.036 | Glutamate (mGluR8) agonist | 0.035 0.033 CID_321710 0.036 0.031 CID_50591 | CID_50591 | |
| 0.044 | 0.043 | 0.044 | Bromodomain-containing protein 3 inhibitor | |||
| 0.019 | 0.018 | 0.019 | Toll-Like receptor 8 agonist | |||
| 0.074 | 0.074 | 0.302 | NMDA receptor antagonist | 0.302 0.006 CID_321710 0.112 0.04 CID_50591 0.118 0.036 CID_524508 | CID_321710 | |
| 0.011 | 0.011 | 0.019 | Carbonic anhydrase XI inhibitor | 0.019 0.004 CID_321710 | CID_321710 | |
| 0.061 | 0.062 | 0.108 | Dopamine antagonist | 0.108 0.036 CID_321710 | CID_321710 | |
| 0.048 | 0.049 | 0.056 | Alpha 1L adrenoreceptor antagonist | 0.056 0.028 CID_524508 | CID_524508 | |
| 0.057 | 0.058 | 0.073 | Protease 3C (Human rhinovirus) inhibitor | 0.073 0.033 CID_321710 | CID_321710 | |
| 0.006 | 0.007 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 CID_321710 | CID_321710 | |
| 0.012 | 0.013 | 0.014 | Melatonin receptor 1A antagonist | 0.014 0.009 CID_321710 | CID_321710 | |
| 0.035 | 0.038 | 0.039 | Liver X receptor alpha agonist | 0.039 0.031 CID_524508 | CID_524508 | |
| 0.055 | 0.057 | 0.079 | Dopamine D1 antagonist | 0.079 0.033 CID_321710 0.06 0.05 CID_50591 0.076 0.035 CID_524508 | CID_321710 | |
| 0.126 | 0.129 | 0.397 | Amyloid beta aggregation inhibitor | 0.397 0.025 CID_50591 0.309 0.044 CID_524508 | CID_50591 | |
| 0.015 | 0.018 | 0.02 | Nicotinic acid receptor 1 antagonist | 0.016 0.015 CID_321710 0.02 0.009 CID_50591 0.02 0.009 CID_524508 | CID_524508 | |
| 0.074 | 0.077 | 0.15 | Alpha adrenoreceptor antagonist | 0.15 0.038 CID_321710 | CID_321710 | |
| 0.112 | 0.116 | 0.121 | Src kinase inhibitor | 0.121 0.107 CID_524508 | CID_524508 | |
| 0.009 | 0.015 | 0.013 | Egl nine homolog 3 inhibitor | 0.013 0.007 CID_50591 | CID_50591 | |
| 0.061 | 0.067 | 0.145 | Alpha 1 adrenoreceptor antagonist | 0.145 0.03 CID_321710 | CID_321710 | |
| 0.019 | 0.025 | 0.029 | Dopamine D1 agonist | 0.029 0.01 CID_524508 | CID_524508 | |
| 0.006 | 0.012 | 0.011 | Thyroid hormone beta agonist | 0.009 0.006 CID_50591 0.011 0.005 CID_524508 | CID_524508 | |
| 0.027 | 0.034 | 0.036 | Melatonin 1 agonist | 0.036 0.019 CID_50591 | CID_50591 | |
| 0.022 | 0.029 | 0.024 | Integrin alpha2beta1 antagonist | 0.024 0.023 CID_321710 | CID_321710 | |
| 0.031 | 0.038 | 0.057 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.057 0.014 CID_321710 | CID_321710 | |
| 0.044 | 0.052 | 0.052 | CD45 antagonist | 0.052 0.032 CID_50591 0.048 0.039 CID_524508 | CID_50591 | |
| 0.025 | 0.033 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.015 CID_50591 0.03 0.017 CID_524508 | CID_524508 | |
| 0.014 | 0.022 | 0.052 | Kainate receptor 1 antagonist | 0.052 0.005 CID_321710 | CID_321710 | |
| 0.028 | 0.038 | 0.036 | Nicotinic acid receptor agonist | 0.036 0.025 CID_321710 0.032 0.03 CID_524508 | CID_321710 | |
| 0.032 | 0.041 | 0.041 | Dihydropteroate synthase inhibitor | 0.041 0.025 CID_524508 | CID_524508 | |
| 0.046 | 0.056 | 0.051 | Sphingosine kinase 2 inhibitor | 0.051 0.045 CID_524508 | CID_524508 | |
| 0.027 | 0.037 | 0.038 | Phosphoglycerate kinase inhibitor | 0.038 0.022 CID_524508 | CID_524508 | |
| 0.034 | 0.045 | 0.044 | Guanylate cyclase inhibitor | 0.039 0.035 CID_321710 0.044 0.028 CID_50591 | CID_50591 | |
| 0.028 | 0.038 | 0.034 | RNA-directed RNA polymerase inhibitor | 0.034 0.025 CID_50591 | CID_50591 | |
| 0.017 | 0.028 | 0.073 | NMDA receptor glycine site antagonist | 0.073 0.004 CID_321710 0.028 0.014 CID_50591 | CID_321710 | |
| 0.053 | 0.065 | 0.135 | Alpha 1a adrenoreceptor antagonist | 0.135 0.026 CID_321710 | CID_321710 | |
| 0.053 | 0.064 | 0.077 | CDC25B inhibitor | 0.077 0.03 CID_50591 0.073 0.035 CID_524508 | CID_50591 | |
| 0.046 | 0.058 | 0.05 | Thromboxane synthase inhibitor | 0.05 0.048 CID_321710 | CID_321710 | |
| 0.016 | 0.03 | 0.064 | Kainate receptor 4 antagonist | 0.064 0.005 CID_321710 | CID_321710 | |
| 0.027 | 0.041 | 0.107 | NMDA receptor subunit 3A antagonist | 0.107 0.008 CID_321710 0.067 0.015 CID_50591 0.053 0.019 CID_524508 | CID_321710 | |
| 0.03 | 0.045 | 0.04 | Adenosine uptake inhibitor | 0.04 0.011 CID_321710 | CID_321710 | |
| 0.052 | 0.066 | 0.061 | Carbonic anhydrase V inhibitor | 0.061 0.052 CID_524508 | CID_524508 | |
| 0.023 | 0.037 | 0.028 | HCV NS5B polymerase inhibitor | 0.028 0.027 CID_50591 0.028 0.027 CID_524508 | CID_524508 | |
| 0.056 | 0.071 | 0.069 | Beta 2 adrenoreceptor agonist | 0.063 0.037 CID_321710 0.061 0.045 CID_50591 0.069 0.02 CID_524508 | CID_524508 | |
| 0.147 | 0.163 | 0.187 | MAP kinase kinase 5 inhibitor | 0.187 0.05 CID_321710 0.157 0.125 CID_524508 | CID_321710 | |
| 0.078 | 0.095 | 0.086 | Potassium channel (Voltage-sensitive) activator | 0.086 0.076 CID_321710 | CID_321710 | |
| 0.026 | 0.044 | 0.043 | Carnitine palmitoyltransferase 1 inhibitor | 0.043 0.013 CID_321710 | CID_321710 | |
| 0.225 | 0.243 | 0.399 | Apoptosis agonist | 0.399 0.114 CID_524508 | CID_524508 | |
| 0.205 | 0.223 | 0.407 | Antibacterial | 0.24 0.186 CID_321710 0.407 0.074 CID_50591 0.259 0.169 CID_524508 | CID_50591 | |
| 0.03 | 0.049 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.032 CID_321710 | CID_321710 | |
| 0.059 | 0.08 | 0.085 | CDC25A inhibitor | 0.085 0.038 CID_50591 0.081 0.042 CID_524508 | CID_50591 | |
| 0.052 | 0.074 | 0.241 | CDK1/cyclin B1 inhibitor | 0.065 0.054 CID_321710 0.241 0.005 CID_50591 | CID_50591 | |
| 0.075 | 0.096 | 0.09 | Sphingomyelinase inhibitor | 0.09 0.072 CID_321710 | CID_321710 | |
| 0.025 | 0.046 | 0.043 | Carnitine palmitoyltransferase inhibitor | 0.043 0.013 CID_321710 | CID_321710 | |
| 0.06 | 0.083 | 0.089 | GABA aminotransferase inhibitor | 0.089 0.037 CID_321710 0.07 0.062 CID_50591 0.072 0.058 CID_524508 | CID_321710 | |
| 0.021 | 0.045 | 0.029 | Glutamate (mGluR2) antagonist | 0.029 0.021 CID_321710 | CID_321710 | |
| 0.046 | 0.07 | 0.092 | Acetylcholine M5 receptor antagonist | 0.092 0.02 CID_321710 | CID_321710 | |
| 0.072 | 0.096 | 0.172 | Monophenol monooxygenase inhibitor | 0.152 0.046 CID_50591 0.172 0.04 CID_524508 | CID_524508 | |
| 0.027 | 0.052 | 0.04 | Glutamate (mGluR group II) antagonist | 0.04 0.025 CID_321710 | CID_321710 | |
| 0.074 | 0.099 | 0.127 | DNA directed RNA polymerase inhibitor | 0.127 0.033 CID_321710 | CID_321710 | |
| 0.054 | 0.08 | 0.087 | Histone deacetylase stimulant | 0.087 0.038 CID_524508 | CID_524508 | |
| 0.054 | 0.08 | 0.087 | Histone deacetylase SIRT1 stimulant | 0.087 0.038 CID_524508 | CID_524508 | |
| 0.014 | 0.04 | 0.06 | Calcitonin gene-related peptide antagonist | 0.06 0.006 CID_321710 | CID_321710 | |
| 0.042 | 0.068 | 0.101 | Dopamine D2 antagonist | 0.101 0.032 CID_321710 | CID_321710 | |
| 0.043 | 0.07 | 0.133 | CDK1/cyclin B inhibitor | 0.133 0.016 CID_321710 0.076 0.036 CID_50591 | CID_321710 | |
| 0.039 | 0.067 | 0.049 | Beta adrenoreceptor agonist | 0.045 0.033 CID_321710 0.049 0.019 CID_524508 | CID_524508 | |
| 0.041 | 0.069 | 0.069 | CXC chemokine 4 receptor antagonist | 0.069 0.036 CID_321710 | CID_321710 | |
| 0.029 | 0.057 | 0.053 | Acid-sensing ion channel blocker | 0.053 0.014 CID_321710 0.041 0.027 CID_50591 | CID_321710 | |
| 0.073 | 0.101 | 0.084 | Hematopoietic | 0.084 0.063 CID_321710 | CID_321710 | |
| 0.097 | 0.125 | 0.189 | Histone deacetylase SIRT1 inhibitor | 0.189 0.035 CID_321710 | CID_321710 | |
| 0.051 | 0.079 | 0.076 | Sirtuin 1 inhibitor | 0.076 0.038 CID_321710 0.064 0.053 CID_50591 | CID_321710 | |
| 0.104 | 0.134 | 0.151 | Vanilloid 1 agonist | 0.151 0.037 CID_321710 0.113 0.105 CID_50591 0.116 0.098 CID_524508 | CID_321710 | |
| 0.01 | 0.04 | 0.031 | Kainate receptor 3 antagonist | 0.031 0.005 CID_321710 | CID_321710 | |
| 0.021 | 0.052 | 0.031 | ATP citrate lysase inhibitor | 0.031 0.023 CID_524508 | CID_524508 | |
| 0.062 | 0.093 | 0.105 | Estrogen receptor alpha antagonist | 0.078 0.052 CID_50591 0.105 0.024 CID_524508 | CID_524508 | |
| 0.011 | 0.042 | 0.027 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.027 0.013 CID_524508 | CID_524508 | |
| 0.025 | 0.058 | 0.043 | Oxytocin agonist | 0.043 0.029 CID_321710 0.037 0.035 CID_524508 | CID_321710 | |
| 0.008 | 0.041 | 0.025 | 5-Alpha-reductase 1 inhibitor | 0.025 0.009 CID_321710 | CID_321710 | |
| 0.038 | 0.071 | 0.049 | HCV NS3/NS4A protease inhibitor | 0.049 0.033 CID_321710 | CID_321710 | |
| 0.014 | 0.048 | 0.026 | Melatonin antagonist | 0.026 0.023 CID_321710 | CID_321710 | |
| 0.108 | 0.143 | 0.173 | Growth hormone agonist | 0.173 0.071 CID_321710 0.146 0.09 CID_50591 0.132 0.104 CID_524508 | CID_321710 | |
| 0.026 | 0.061 | 0.071 | Factor XIa inhibitor | 0.071 0.009 CID_321710 | CID_321710 | |
| 0.01 | 0.045 | 0.039 | Kainate receptor 5 antagonist | 0.039 0.007 CID_321710 | CID_321710 | |
| 0.011 | 0.047 | 0.02 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 CID_321710 | CID_321710 | |
| 0.05 | 0.086 | 0.073 | Carbonic anhydrase XIII inhibitor | 0.073 0.056 CID_524508 | CID_524508 | |
| 0.101 | 0.139 | 0.185 | Acetylcholine M1 receptor antagonist | 0.185 0.049 CID_321710 | CID_321710 | |
| 0.015 | 0.053 | 0.073 | Acetylcholine M4 receptor agonist | 0.073 0.007 CID_321710 | CID_321710 | |
| 0.009 | 0.048 | 0.02 | Calcitonin gene-related peptide 1 receptor antagonist | 0.02 0.009 CID_321710 | CID_321710 | |
| 0.087 | 0.126 | 0.104 | Cyclooxygenase 3 inhibitor | 0.104 0.097 CID_321710 | CID_321710 | |
| 0.013 | 0.052 | 0.021 | Beta 1 adrenoreceptor agonist | 0.021 0.018 CID_524508 | CID_524508 | |
| 0.063 | 0.102 | 0.08 | Neuropeptide Y antagonist | 0.08 0.058 CID_321710 | CID_321710 | |
| 0.067 | 0.108 | 0.1 | Breast cancer-resistant protein inhibitor | 0.1 0.055 CID_524508 | CID_524508 | |
| 0.021 | 0.063 | 0.074 | 5 Hydroxytryptamine 2C agonist | 0.074 0.013 CID_321710 | CID_321710 | |
| 0.05 | 0.092 | 0.099 | Glutamate receptor agonist | 0.099 0.038 CID_321710 | CID_321710 | |
| 0.012 | 0.055 | 0.034 | Progesterone receptor B antagonist | 0.034 0.004 CID_321710 | CID_321710 | |
| 0.109 | 0.154 | 0.141 | Neuropeptide Y1 antagonist | 0.141 0.079 CID_321710 | CID_321710 | |
| 0.049 | 0.095 | 0.069 | Glutamate (mGluR group I) antagonist | 0.069 0.049 CID_321710 | CID_321710 | |
| 0.134 | 0.181 | 0.215 | Spasmolytic | 0.215 0.108 CID_321710 | CID_321710 | |
| 0.096 | 0.145 | 0.172 | Diuretic | 0.172 0.059 CID_321710 | CID_321710 | |
| 0.152 | 0.201 | 0.234 | Lipoxygenase inhibitor | 0.234 0.111 CID_50591 0.223 0.119 CID_524508 | CID_50591 | |
| 0.021 | 0.07 | 0.047 | Factor XI inhibitor | 0.047 0.011 CID_321710 | CID_321710 | |
| 0.127 | 0.178 | 0.163 | Immunostimulant | 0.163 0.144 CID_321710 0.154 0.151 CID_524508 | CID_321710 | |
| 0.038 | 0.089 | 0.055 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.055 0.046 CID_524508 | CID_524508 | |
| 0.016 | 0.068 | 0.048 | 5-Alpha-reductase inhibitor | 0.048 0.019 CID_321710 | CID_321710 | |
| 0.08 | 0.132 | 0.136 | Caspase 3 inhibitor | 0.136 0.039 CID_321710 0.107 0.08 CID_50591 | CID_321710 | |
| 0.071 | 0.126 | 0.103 | c-Src kinase inhibitor | 0.103 0.087 CID_524508 | CID_524508 | |
| 0.054 | 0.11 | 0.113 | Phosphodiesterase 3A inhibitor | 0.113 0.025 CID_321710 | CID_321710 | |
| 0.045 | 0.106 | 0.101 | Cathepsin G inhibitor | 0.101 0.033 CID_321710 | CID_321710 | |
| 0.021 | 0.082 | 0.067 | Acetylcholine M1 receptor agonist | 0.067 0.02 CID_321710 | CID_321710 | |
| 0.033 | 0.098 | 0.116 | NMDA 2B receptor antagonist | 0.116 0.012 CID_321710 0.075 0.023 CID_524508 | CID_321710 | |
| 0.046 | 0.113 | 0.094 | Glutamate (mGluR) antagonist | 0.094 0.038 CID_321710 | CID_321710 | |
| 0.028 | 0.096 | 0.08 | Acetylcholine muscarinic agonist | 0.08 0.022 CID_321710 | CID_321710 | |
| 0.015 | 0.084 | 0.101 | Kinesin-like protein 1 inhibitor | 0.101 0.008 CID_321710 | CID_321710 | |
| 0.015 | 0.084 | 0.101 | Kinesin antagonist | 0.101 0.008 CID_321710 | CID_321710 | |
| 0.156 | 0.225 | 0.224 | Immunomodulator | 0.224 0.138 CID_321710 | CID_321710 | |
| 0.044 | 0.115 | 0.102 | Topoisomerase II alpha inhibitor | 0.102 0.038 CID_524508 | CID_524508 | |
| 0.066 | 0.137 | 0.096 | EphA2 antagonist | 0.096 0.08 CID_524508 | CID_524508 | |
| 0.036 | 0.108 | 0.053 | Dipeptidyl peptidase inhibitor | 0.053 0.037 CID_321710 | CID_321710 | |
| 0.063 | 0.141 | 0.084 | Thioredoxin inhibitor | 0.084 0.072 CID_524508 | CID_524508 | |
| 0.071 | 0.15 | 0.115 | Cholinergic antagonist | 0.115 0.078 CID_321710 | CID_321710 | |
| 0.069 | 0.149 | 0.112 | Acetylcholine antagonist | 0.112 0.077 CID_321710 | CID_321710 | |
| 0.04 | 0.124 | 0.068 | Histone deacetylase SIRT2 inhibitor | 0.068 0.058 CID_321710 | CID_321710 | |
| 0.01 | 0.095 | 0.088 | Dipeptidyl peptidase I inhibitor | 0.088 0.005 CID_321710 | CID_321710 | |
| 0.048 | 0.136 | 0.152 | Antiadrenergic | 0.152 0.035 CID_321710 | CID_321710 | |
| 0.163 | 0.251 | 0.287 | Alpha-glucosidase inhibitor | 0.287 0.166 CID_321710 0.228 0.201 CID_524508 | CID_321710 | |
| 0.009 | 0.098 | 0.058 | AMPA 2 receptor antagonist | 0.058 0.009 CID_321710 | CID_321710 | |
| 0.046 | 0.135 | 0.149 | Adrenaline antagonist | 0.149 0.035 CID_321710 | CID_321710 | |
| 0.069 | 0.159 | 0.1 | Epidermal growth factor receptor kinase inhibitor | 0.1 0.098 CID_524508 | CID_524508 | |
| 0.058 | 0.149 | 0.153 | Topoisomerase II inhibitor | 0.114 0.072 CID_50591 0.153 0.048 CID_524508 | CID_524508 | |
| 0.017 | 0.111 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.016 CID_321710 | CID_321710 | |
| 0.022 | 0.117 | 0.077 | Dopamine D4 agonist | 0.077 0.02 CID_321710 | CID_321710 | |
| 0.063 | 0.158 | 0.123 | Histone deacetylase class III inhibitor | 0.123 0.067 CID_321710 | CID_321710 | |
| 0.022 | 0.118 | 0.092 | Alpha tubulin antagonist | 0.049 0.042 CID_50591 0.092 0.016 CID_524508 | CID_524508 | |
| 0.024 | 0.127 | 0.078 | Phosphodiesterase 4C inhibitor | 0.078 0.022 CID_321710 | CID_321710 | |
| 0.006 | 0.11 | 0.027 | Prostaglandin EP3 antagonist | 0.027 0.025 CID_321710 | CID_321710 | |
| 0.023 | 0.128 | 0.058 | Acetylcholine M2 receptor antagonist | 0.058 0.047 CID_321710 | CID_321710 | |
| 0.029 | 0.136 | 0.093 | HIV-1 reverse transcriptase inhibitor | 0.093 0.034 CID_321710 | CID_321710 | |
| 0.046 | 0.154 | 0.135 | Topoisomerase I inhibitor | 0.135 0.048 CID_524508 | CID_524508 | |
| 0.16 | 0.272 | 0.332 | Interleukin 2 agonist | 0.332 0.054 CID_321710 0.204 0.182 CID_50591 0.233 0.139 CID_524508 | CID_321710 | |
| 0.02 | 0.139 | 0.037 | Nicotinic acid receptor 1 agonist | 0.037 0.032 CID_321710 | CID_321710 | |
| 0.017 | 0.136 | 0.042 | Estrogen-related receptor beta antagonist | 0.042 0.009 CID_524508 | CID_524508 | |
| 0.021 | 0.143 | 0.056 | Acetylcholine M3 receptor antagonist | 0.056 0.046 CID_321710 | CID_321710 | |
| 0.205 | 0.327 | 0.305 | Antiinflammatory | 0.305 0.211 CID_524508 | CID_524508 | |
| 0.014 | 0.137 | 0.085 | Beta tubulin antagonist | 0.085 0.027 CID_524508 | CID_524508 | |
| 0.053 | 0.192 | 0.124 | Acetylcholine muscarinic antagonist | 0.124 0.063 CID_321710 | CID_321710 | |
| 0.069 | 0.219 | 0.152 | Cholinergic | 0.152 0.075 CID_321710 | CID_321710 | |
| 0.102 | 0.253 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.096 CID_524508 | CID_524508 | |
| 0.057 | 0.211 | 0.123 | Acetylcholinesterase inhibitor | 0.123 0.075 CID_321710 | CID_321710 | |
| 0.028 | 0.204 | 0.067 | Antiviral (Hepatitis D) | 0.067 0.016 CID_321710 | CID_321710 | |
| 0.008 | 0.186 | 0.051 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.051 0.015 CID_524508 | CID_524508 | |
| 0.071 | 0.258 | 0.133 | Dual specificity phosphatase inhibitor | 0.133 0.115 CID_524508 | CID_524508 | |
| 0.052 | 0.245 | 0.091 | Toll-Like receptor 4 antagonist | 0.091 0.086 CID_524508 | CID_524508 | |
| 0.004 | 0.198 | 0.026 | Nociceptin (N/OFQ) receptor agonist | 0.026 0.011 CID_321710 | CID_321710 | |
| 0.059 | 0.254 | 0.149 | Interleukin 4 antagonist | 0.149 0.051 CID_524508 | CID_524508 | |
| 0.099 | 0.294 | 0.193 | Thyroid hormone antagonist | 0.193 0.168 CID_321710 | CID_321710 | |
| 0.097 | 0.301 | 0.185 | Thyroid hormone beta antagonist | 0.185 0.168 CID_321710 | CID_321710 | |
| 0.006 | 0.217 | 0.026 | Carnitine palmitoyltransferase 1A inhibitor | 0.026 0.025 CID_321710 | CID_321710 | |
| 0.005 | 0.228 | 0.087 | Nociceptin (N/OFQ) receptor antagonist | 0.087 0.007 CID_321710 | CID_321710 | |
| 0.072 | 0.301 | 0.303 | Free radical scavenger | 0.189 0.107 CID_50591 0.303 0.051 CID_524508 | CID_524508 | |
| 0.037 | 0.268 | 0.219 | Chelator | 0.219 0.021 CID_50591 0.116 0.058 CID_524508 | CID_50591 | |
| 0.018 | 0.256 | 0.093 | CXC chemokine receptor antagonist | 0.093 0.028 CID_321710 | CID_321710 | |
| 0.008 | 0.248 | 0.032 | Catechol O-methyltransferase inhibitor | 0.032 0.024 CID_524508 | CID_524508 | |
| 0.025 | 0.266 | 0.125 | M18 aspartyl aminopeptidase inhibitor | 0.125 0.067 CID_524508 | CID_524508 | |
| 0.078 | 0.325 | 0.119 | Papain-like protease (SARS coronavirus) inhibitor | 0.119 0.083 CID_524508 | CID_524508 | |
| 0.041 | 0.298 | 0.125 | Bone formation stimulant | 0.125 0.081 CID_524508 | CID_524508 | |
| 0.008 | 0.267 | 0.035 | Vasopressin 2 antagonist | 0.035 0.021 CID_321710 | CID_321710 | |
| 0.024 | 0.292 | 0.081 | 5-Lipoxygenase inhibitor | 0.081 0.08 CID_524508 | CID_524508 | |
| 0.004 | 0.273 | 0.049 | Vasopressin 1A antagonist | 0.049 0.013 CID_321710 | CID_321710 | |
| 0.073 | 0.345 | 0.254 | Cardiotonic | 0.254 0.08 CID_321710 | CID_321710 | |
| 0.044 | 0.317 | 0.091 | Nav1.1 sodium channel blocker | 0.091 0.078 CID_321710 | CID_321710 | |
| 0.114 | 0.388 | 0.238 | Caspase 3 stimulant | 0.238 0.123 CID_524508 | CID_524508 | |
| 0.024 | 0.306 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.046 CID_50591 0.07 0.048 CID_524508 | CID_50591 | |
| 0.035 | 0.333 | 0.17 | Lipid peroxidase inhibitor | 0.17 0.056 CID_524508 | CID_524508 | |
| 0.059 | 0.37 | 0.241 | Vasodilator | 0.241 0.074 CID_321710 | CID_321710 | |
| 0.102 | 0.417 | 0.203 | Apoptosis antagonist | 0.203 0.175 CID_524508 | CID_524508 | |
| 0.004 | 0.32 | 0.044 | Vasopressin 1 antagonist | 0.044 0.016 CID_321710 | CID_321710 | |
| 0.04 | 0.357 | 0.2 | Estrogen antagonist | 0.111 0.073 CID_50591 0.2 0.013 CID_524508 | CID_524508 | |
| 0.015 | 0.334 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.028 CID_321710 | CID_321710 | |
| 0.005 | 0.342 | 0.08 | Antidiuretic hormone antagonist | 0.08 0.016 CID_321710 | CID_321710 | |
| 0.021 | 0.404 | 0.171 | Acetylcholine M3 receptor agonist | 0.171 0.01 CID_321710 | CID_321710 | |
| 0.047 | 0.432 | 0.261 | Antioxidant | 0.26 0.079 CID_50591 0.261 0.078 CID_524508 | CID_524508 | |
| 0.01 | 0.408 | 0.342 | Maillard reaction inhibitor | 0.342 0.003 CID_50591 | CID_50591 | |
| 0.009 | 0.421 | 0.047 | p53 inhibitor | 0.047 0.015 CID_321710 | CID_321710 | |
| 0.003 | 0.421 | 0.071 | Estrogen receptor beta agonist | 0.071 0.016 CID_524508 | CID_524508 | |
| 0.017 | 0.447 | 0.035 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.032 CID_321710 | CID_321710 | |
| 0.07 | 0.507 | 0.256 | Sodium/bile acid cotransporter inhibitor | 0.234 0.146 CID_50591 0.256 0.122 CID_524508 | CID_524508 | |
| 0.034 | 0.515 | 0.127 | Nitric oxide antagonist | 0.127 0.124 CID_524508 | CID_524508 | |
| 0.007 | 0.511 | 0.068 | Acetylcholine M2 receptor agonist | 0.068 0.021 CID_321710 | CID_321710 | |
| 0.002 | 0.515 | 0.043 | Estrogen receptor alpha agonist | 0.043 0.019 CID_524508 | CID_524508 | |
| 0.014 | 0.546 | 0.157 | Estrogen receptor beta antagonist | 0.097 0.07 CID_50591 0.157 0.014 CID_524508 | CID_524508 | |
| 0.004 | 0.577 | 0.064 | Estrogen agonist | 0.064 0.028 CID_524508 | CID_524508 | |
| 0.037 | 0.694 | 0.261 | Cyclophilin D inhibitor | 0.261 0.201 CID_50591 | CID_50591 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |